Combined T and B Cell Immunodeficiencies

  • Françoise Le Deist
  • Despina Moshous
  • Steven J. Howe
  • Amit Nahum
  • Fotini D. Kavadas
  • Elana Lavine
  • Chaim M. Roifman
  • Alain Fischer
  • Combined immunodeficiency comprises a heterogeneous group of disorders, characterized by lack of T cell-mediated immunity and impaired B cell function.

  • Combined immunodeficiency has most often an early onset, frequently with protracted diarrhea, interstitial pneumonia, recurrent or persistent candidiasis, and failure to thrive.

  • Infections are sustained by intracellular pathogens (especially Pneumocystis jiroveci), viruses, bacteria, and fungi.

  • Use of live vaccines and of unirradiated blood products is highly contraindicated in infants with severe combined immunodeficiency (SCID).

  • Maternal T cell engraftment is common in SCID. It may cause “graft-versus-host”-like features, but may also occur without specific symptoms.

  • Family history is of paramount importance. Some combined immunodeficiencies inherited as an X-linked trait, but several autosomal recessive forms exist, which altogether comprise the majority of cases.

  • Lymphopenia is a laboratory hallmark of SCID. However, normal lymphocyte count may be observed in some forms of SCID, especially if maternal T cell engraftment is present or if the defect allows for residual T cell development.

  • Hypomorphic defects may lead to leaky forms of SCID, with residual T cell development. Autoimmune manifestations are common in this setting.

  • Hematopoietic stem cell transplantation is the treatment of choice for SCID, and can cure more than 70% of the affected patients. Promising results have been achieved with gene therapy, although long-term safety remains an issue.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Abuzzahab MJ, Schneider A, Goddard A, Grigorescu F, Lautier C, Keller E, Kiess W, Klammt J, Kratzsch J, Osgood D, Pfaffle R, Raile K, Seidel B, Smith RJ, Chernausek SD (2003) IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. N Engl J Med 349:2211–2222PubMedCrossRefGoogle Scholar
  2. 2.
    Adriani M, Martinez-Mir A, Fusco F, Busiello R, Frank J, Telese S, Matrecano E, Ursini MV, Christiano AM, Pignata C (2004) Ancestral founder mutation of the nude (FOXN1) gene in congenital severe combined immunodeficiency associated with alopecia in southern Italy population. Ann Hum Genet 68:265–268PubMedCrossRefGoogle Scholar
  3. 3.
    Agematsu K, Nagumo H, Shinozaki K, Hokibara S, Yasui K, Terada K, Kawamura N, Toba T, Nonoyama S, Ochs HD, Komiyama A (1998) Absence of IgD-CD27(+) memory B cell population in X-linked hyper-IgM syndrome. J Clin Invest 102:853–860PubMedCrossRefGoogle Scholar
  4. 4.
    Agrawal A, Eastman QM, Schatz DG (1998) Transposition mediated by RAG1 and RAG2 and its implications for the evolution of the immune system. Nature 394:744–751PubMedCrossRefGoogle Scholar
  5. 5.
    Agrawal A, Schatz DG (1997) RAG1 and RAG2 form a stable postcleavage synaptic complex with DNA containing signal ends in V(D) J recombination. Cell 89:43–53PubMedCrossRefGoogle Scholar
  6. 6.
    Ahnesorg P, Smith P, Jackson SP (2006) XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining. Cell 124:301–313PubMedCrossRefGoogle Scholar
  7. 7.
    Aiuti A, Slavin S, Aker M, Ficara F, Deola S, Mortello A, Morecki S, Andolfi G, Tabucchi A, Carlucci F, Marinello E, Cattaneo F, Vai S, Servida P, Miniero R, Roncarolo M, Bordignon C (2002) Correction of ADA-SCPI by stem cell gene therapy combined with nonmyeloablative conditioning. Science 296:2410–2413PubMedCrossRefGoogle Scholar
  8. 8.
    Akira S (1999) Functional roles of STAT family proteins: lessons from knockout mice. Stem Cells 17:138–146PubMedCrossRefGoogle Scholar
  9. 9.
    Alarcon B, Regueiro JR, Arnaiz-Villena A, Terhorst C (1988) Familial defect in the surface expression of the T cell receptor-CD3 complex. N Engl J Med 319:1203–1208PubMedGoogle Scholar
  10. 10.
    Alderson MR, Armitage RJ, Tough TW, Strockbine L, Fanslow WC, Spriggs MK (1993) CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J Exp Med 178:669–674PubMedCrossRefGoogle Scholar
  11. 11.
    Allen RC, Armitage RJ, Conley ME, Rosenblatt H, Jenkins NA, Copeland NG, Bedell MA, Edelhoff S, Disteche CM, Simoneaux DK, et al. (1993) CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 259:990–993PubMedCrossRefGoogle Scholar
  12. 12.
    Amos DB, Bach F (1968) Phenotypic expression of the major histocompatibility locus in man (HLA-A): leukocyte antigens and mixed leukocyte culture reactivity. J Exp Med 128:623–637PubMedCrossRefGoogle Scholar
  13. 13.
    Amrolia P, Gaspar HB, Hassan A, Webb D, Jones A, Sturt N, Mieli-Vergani G, Pagliuca A, Mufti G, Hadzic N, Davies G, Veys P (2000) Nonmyeloablative stem cell transplantation for congenital immunodeficiencies. Blood 96:1239–1246PubMedGoogle Scholar
  14. 14.
    Andrews LG, Markert ML (1992) Exon skipping in purine nucleoside phosphorylase mRNA processing leading to severe immunodeficiency. J Biol Chem 267:7834–7838PubMedGoogle Scholar
  15. 15.
    Annacker O, Pimenta-Araujo R, Burlen-Defranoux O, Barbosa TC, Cumano A, Bandeira A (2001) CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J Immunol 166:3008–3018PubMedGoogle Scholar
  16. 16.
    Antoine C, Muller S, Cant A, Cavazzana-Calvo M, Veys P, Vossen J, Fasth A, Heilmann C, Wulffraat N, Seger R, Blanche S, Friedrich W, Abinun M, Davies G, Bredius R, Schulz A, Landais P, Fischer A (2003) Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99. Lancet 361:553–560PubMedCrossRefGoogle Scholar
  17. 17.
    Aoki CA, Roifman CM, Lian ZX, Bowlus CL, Norman GL, Shoenfeld Y, Mackay IR, Gershwin ME (2006) IL-2 receptor alpha deficiency and features of primary biliary cirrhosis. J Autoimmun 27:50–53PubMedCrossRefGoogle Scholar
  18. 18.
    Arnaiz-Villena A, Timon M, Correl A, Perez-Aciego P, Martin-Villa JM, Regueiro JR (1992) Primary Immunodeficiency caused by mutations in the gene encoding the CD3-gamma subunit of the T-lymphocyte receptor. N Engl J Med 327:529–533PubMedGoogle Scholar
  19. 19.
    Arpaia E, Benveniste P, Di Cristofano A, Gu Y, Dalal I, Kelly S, Hershfield M, Pandolfi PP, Roifman CM, Cohen A (2000) Mitochondrial basis for immune deficiency. Evidence from purine nucleoside phosphorylase-deficient mice. J Exp Med 191:2197–2208PubMedCrossRefGoogle Scholar
  20. 20.
    Arpaia E, Shahar M, Dadi H, Cohen A, Roifman CM (1994) Defective T cell receptor signaling and CD8+ thymic selection in humans lacking zap-70 kinase. Cell 76:947–958PubMedCrossRefGoogle Scholar
  21. 21.
    Aruffo A, Farrington M, Hollenbaugh D, Li X, Milatovich A, Nonoyama S, Bajorath J, Grosmaire LS, Stenkamp R, Neubauer M, et al. (1993) The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72:291–300PubMedCrossRefGoogle Scholar
  22. 22.
    Asao H, Okuyama C, Kumaki S, Ishii J, Tsuchiya S, Forster D, Sugamura K (2001) Cutting edge: the common gamma chain is an indispensable subunit of the IL-21 receptor complex. J Immunol 167:1–5PubMedGoogle Scholar
  23. 23.
    Aust MR, Andrews LG, Barrett MJ, Norby-Slycord CJ, Markert ML (1992) Molecular analysis of mutations in a patient with purine nucleoside phosphorylase deficiency. Am J Hum Genet 51:763–772PubMedGoogle Scholar
  24. 24.
    Bach F, Albertini R, Joo P, Anderson J, Bortin M (1968) Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet 2:1364–1366PubMedCrossRefGoogle Scholar
  25. 25.
    Baguette C, Vermylen C, Brichard B, Louis J, Dahan K, Vincent MF, Cornu G (2002) Persistent developmental delay despite successful bone marrow transplantation for purine nucleoside phosphorylase deficiency. J Pediatr Hematol Oncol 24:69–71PubMedCrossRefGoogle Scholar
  26. 26.
    Bartolome J, Porta F, Lafranchi A, Rodriguez-Molina JJ, Cela E, Cantalejo A, Fernandez-Cruz E, Gomez-Pineda A, Ugazio AG, Notarangelo LD, Gil J (2002) B cell function after haploidentical in utero bone marrow transplantation in a patient with severe combined immunodeficiency. Bone Marrow Transplant 29:625–628PubMedCrossRefGoogle Scholar
  27. 27.
    Beggs J, Campagnoli C, Sullivan KE, Johnson MP, Puck JM, Zanjani ED, Flake AW (2003) Eight years later. T and B cell-function in a patient transplanted in utero for X-linked severe combined immunodeficiency. Blood 102 (Suppl 2):480bCrossRefGoogle Scholar
  28. 28.
    Bejaoui M, Barbouche MR, Mellouli F, Largueche B, Dellagi K (1998) [Primary immunologic deficiency by deficiency of HLA class II antigens: nine new Tunisian cases]. Arch Pediatr 5:1089–1093PubMedCrossRefGoogle Scholar
  29. 29.
    Belkaid Y, Rouse BT (2005) Natural regulatory T cells in infectious disease. Nat Immunol 6:353–360PubMedCrossRefGoogle Scholar
  30. 30.
    Ben-Omran TI, Cerosaletti K, Concannon P, Weitzman S, Nezarati MM (2005) A patient with mutations in DNA Ligase IV: clinical features and overlap with Nijmegen breakage syndrome. Am J Med Genet A 137:283–287Google Scholar
  31. 31.
    Besmer E, Mansilla-Soto J, Cassard S, Sawchuk DJ, Brown G, Sadofsky M, Lewis SM, Nussenzweig MC, Cortes P (1998) Hairpin coding end opening is mediated by RAG1 and RAG2 proteins. Mol Cell 2:817–828PubMedCrossRefGoogle Scholar
  32. 32.
    Biggar WD, Giblett ER, Ozere RL, Grover BD (1978) A new form of nucleoside phosphorylase deficiency in two brothers with defective T cell function. J Pediatr 92:354–357PubMedCrossRefGoogle Scholar
  33. 33.
    Blaeser F, Kelly M, Siegrist K, Storch GA, Buller RS, Whitlock J, Truong N, Chatila TA (2005) Critical function of the CD40 pathway in parvovirus B19 infection revealed by a hypomorphic CD40 ligand mutation. Clin Immunol 117:231–237PubMedCrossRefGoogle Scholar
  34. 34.
    Bordigoni P, Auburtin B, Carret AS, Schuhmacher A, Humbert JC, Le Deist F, Sommelet D (1998) Bone marrow transplantation as treatment for X-linked immunodeficiency with hyper-IgM. Bone Marrow Transplant 22:1111–1114PubMedCrossRefGoogle Scholar
  35. 35.
    Bordin G, Ballare M, Paglino S, Ravanini P, Dulio D, Malosso MC, Boldorini R, Monteverde A (1996) Idiopathic CD4+ lymphocytopenia and systemic vasculitis. J Intern Med 240:37–41PubMedCrossRefGoogle Scholar
  36. 36.
    Bortin M, Rimm AA (1977) Severe combined immunodeficiceny disease. Characterization of the disease and results of transplantation. JAMA 238:591–600PubMedCrossRefGoogle Scholar
  37. 37.
    Bousso P, Wahn V, Douagl I, Horneff G, Pannetier C, Le Deist F, al. e (2000) Diversity, functionality, and stability of the T cell repertoire derived in vivo from a single human T cell precursor. Proc Natl Acad Sci USA 97:274–278PubMedCrossRefGoogle Scholar
  38. 38.
    Brand OJ, Lowe CE, Heward JM, Franklyn JA, Cooper JD, Todd JA, Gough SC (2007) Association of the interleukin-2 receptor alpha (IL-2Ralpha)/CD25 gene region with Graves’ disease using a multilocus test and tag SNPs. Clin Endocrinol (Oxf) 66:508–512Google Scholar
  39. 39.
    Buck D, Malivert L, de Chasseval R, Barraud A, Fondaneche MC, Sanal O, Plebani A, Stephan JL, Hufnagel M, le Deist F, Fischer A, Durandy A, de Villartay JP, Revy P (2006) Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly. Cell 124:287–299PubMedCrossRefGoogle Scholar
  40. 40.
    Buck D, Moshous D, de Chasseval R, Ma Y, le Deist F, Cavazzana-Calvo M, Fischer A, Casanova JL, Lieber MR, de Villartay JP (2006) Severe combined immunodeficiency and microcephaly in siblings with hypomorphic mutations in DNA ligase IV. Eur J Immunol 36:224–235PubMedCrossRefGoogle Scholar
  41. 41.
    Buckley R (2004) A historical review of bone marrow transplantation for immunodeficiencies. J Allergy Clin Immunol:793–800Google Scholar
  42. 42.
    Buckley R (2004) Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu Rev Immunol 22:625–655PubMedCrossRefGoogle Scholar
  43. 43.
    Buckley RH (1994) Breakthroughs in the understanding and therapy of primary immunodeficiency. Pediatr Clin North Am 41:665–690PubMedGoogle Scholar
  44. 44.
    Buckley RH (2000) Primary immunodeficiency diseases due to defects in lymphocytes. N Engl J Med 343:1313–1324PubMedCrossRefGoogle Scholar
  45. 45.
    Buckley RH (2004) Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu Rev Immunol 22:625–655PubMedCrossRefGoogle Scholar
  46. 46.
    Buckley RH (2004) The multiple causes of human SCID. J Clin Invest 114:1409–1411PubMedGoogle Scholar
  47. 47.
    Buckley RH, Schiff RI, Schiff SE, Markert ML, Williams LW, Harville TO, Roberts JL, Puck JM (1997) Human severe combined immunodeficiency (SCID): genetic, phenotypic and functional diversity in 108 infants. J Pediatr 130:378–387PubMedCrossRefGoogle Scholar
  48. 48.
    Buettner R, Mora LB, Jove R (2002) Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res 8:945–954PubMedGoogle Scholar
  49. 49.
    Bunting KD, Sangster MY, Ihle JN, Sorrentino BP (1998) Restoration of lymphocyte function in Janus kinase 3-deficient mice by retroviral mediated gene transfer. Nat Med 4:58–64PubMedCrossRefGoogle Scholar
  50. 50.
    Busse PJ, Cunningham-Rundles C (2002) Primary leptomeningeal lymphoma in a patient with concomitant CD4+ lymphocytopenia. Ann Allergy Asthma Immunol 88:339–342PubMedCrossRefGoogle Scholar
  51. 51.
    Cabrera CM (2007) The double role of the endoplasmic reticulum chaperone tapasin in peptide optimization of HLA class I molecules. Scand J Immunol 65:487–493PubMedCrossRefGoogle Scholar
  52. 52.
    Cacciapuoti G, Porcelli M, Bertoldo C, Fusco S, De Rosa M, Zappia V (1996) Extremely thermophilic and thermostable 5m-methylthioadenosine phosphorylase from the archaeon Sulfolobus solfataricus. Gene cloning and amino acid sequence determination. Eur J Biochem 239:632–637PubMedCrossRefGoogle Scholar
  53. 53.
    Callebaut I, Malivert L, Fischer A, Mornon JP, Revy P, de Villartay JP (2006) Cernunnos interacts with the XRCC4 x DNA-ligase IV complex and is homologous to the yeast nonhomologous end-joining factor Nej1. J Biol Chem 281:13857–13860PubMedCrossRefGoogle Scholar
  54. 54.
    Calo V, Migliavacca M, Bazan V, Macaluso M, Buscemi M, Gebbia N, Russo A (2003) STAT proteins: from normal control of cellular events to tumorigenesis. J Cell Physiol 197:157–168PubMedCrossRefGoogle Scholar
  55. 55.
    Campbell JK, Prince HM, Juneja SK, Seymour JF, Slavin M (2001) Diffuse large cell lymphoma and t(8;22) (q24;q11) in a patient with idiopathic CD4+ T-lymphopenia. Leuk Lymphoma 41:421–423PubMedCrossRefGoogle Scholar
  56. 56.
    Candotti F, Oakes SA, Johnston JA, Notarangelo LD, O’Shea JJ, Blaese RM (1996) In vitro correction of JAK3-deficient severe combined immunodeficiency by retroviral-mediated gene transduction. J Exp Med 183:2687–2692PubMedCrossRefGoogle Scholar
  57. 57.
    Cao H, Dronadula N, Rizvi F, Li Q, Srivastava K, Gerthoffer WT, Rao GN (2006) Novel role for STAT-5B in the regulation of Hsp27-FGF-2 axis facilitating thrombin-induced vascular smooth muscle cell growth and motility. Circ Res 98:913–922PubMedCrossRefGoogle Scholar
  58. 58.
    Carpenter PA, Ziegler JB, Vowels MR (1996) Late diagnosis and correction of purine nucleoside phosphorylase deficiency with allogeneic bone marrow transplantation. Bone Marrow Transplant 17:121–124PubMedGoogle Scholar
  59. 59.
    Carson DA, Carrera CJ (1990) Immunodeficiency secondary to adenosine deaminase deficiency and purine nucleoside phosphorylation deficiency. Semin Hematol 27:260–269PubMedGoogle Scholar
  60. 60.
    Carson DA, Kaye J, Seegmiller JE (1977) Lymphospecific toxicity in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency: possible role of nucleoside kinase(s). Proc Natl Acad Sci USA 74:5677–5681PubMedCrossRefGoogle Scholar
  61. 61.
    Caudy AA, Reddy ST, Chatila T, Atkinson JP, Verbsky JW (2007) CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes. J Allergy Clin Immunol 119:482–487PubMedCrossRefGoogle Scholar
  62. 62.
    Caux C, Massacrier C, Vanbervliet B, Dubois B, Van Kooten C, Durand I, Banchereau J (1994) Activation of human dendritic cells through CD40 cross-linking. J Exp Med 180:1263–1272PubMedCrossRefGoogle Scholar
  63. 63.
    Cavazzana-Calvo M, Fischer A (2007) Gene therapy for severe combined immunodeficiency: are we there yet? J Clin Invest 117:1456–1465PubMedCrossRefGoogle Scholar
  64. 64.
    Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, Gross F, Yvon E, Nusbaum P, Selz F, Hue C, Certain S, Casanova JL, Bousso P, Deist FL, Fischer A (2000) Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288:669–672PubMedCrossRefGoogle Scholar
  65. 65.
    Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, Alber G (1996) Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 184:747–752PubMedCrossRefGoogle Scholar
  66. 66.
    Cerundolo V, de la Salle H (2006) Description of HLA class I- and CD8-deficient patients: Insights into the function of cytotoxic T lymphocytes and NK cells in host defense. Semin Immunol 18:330–336PubMedCrossRefGoogle Scholar
  67. 67.
    Chan AC, Iwashima M, Turck CW, Weiss A (1992) ZAP-70: a 70 kd protein-tyrosine kinase that associates with the TCR zeta chain. Cell 71:649–662PubMedCrossRefGoogle Scholar
  68. 68.
    Chan AC, Kadlecek TA, Elder ME, Filipovich AH, Kuo WL, Iwashima M, Parslow TG, Weiss A (1994) ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency. Science 264:1599–1601PubMedCrossRefGoogle Scholar
  69. 69.
    Chan FK, Chun HJ, Zheng L, Siegel RM, Bui KL, Lenardo MJ (2000) A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science 288:2351–2354PubMedCrossRefGoogle Scholar
  70. 70.
    Chatila TA, Blaeser F, Ho N, Lederman HM, Voulgaropoulos C, Helms C, Bowcock AM (2000) JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest 106:R75–81PubMedCrossRefGoogle Scholar
  71. 71.
    Chilosi M, Facchetti F, Notarangelo LD, Romagnani S, Del Prete G, Almerigogna F, De Carli M, Pizzolo G (1996) CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn’s syndrome: evidence for a T helper 2-mediated condition. Eur J Immunol 26:329–334PubMedCrossRefGoogle Scholar
  72. 72.
    Chinen J, Puck JM, Davis J, Linton G, Whiting-Theobald N, Woltz P, Buckley RH, Malech H (2004) Ex-vivo gene therapy of a preadolescent with X-linked severe combined immunodeficiency. Blood 104:410Google Scholar
  73. 73.
    Classen CF, Schulz AS, Sigl-Kraetzig M, Hoffmann GF, Simmonds HA, Fairbanks L, Debatin KM, Friedrich W (2001) Successful HLA-identical bone marrow transplantation in a patient with PNP deficiency using busulfan and fludarabine for conditioning. Bone Marrow Transplant 28:93–96PubMedCrossRefGoogle Scholar
  74. 74.
    Cohen A, Doyle D, Martin DW, Jr., Ammann AJ (1976) Abnormal purine metabolism and purine overproduction in a patient deficient in purine nucleoside phosphorylase. N Engl J Med 295:1449–1454PubMedGoogle Scholar
  75. 75.
    Cohen A, Grunebaum E, Arpaia E, Roifman CM (2000) Immunodeficiency caused by purine nucleoside phosphorylase deficiency. Immunol Allergy Clin North Am 20:143–159CrossRefGoogle Scholar
  76. 76.
    Cohen A, Lee JW, Dosch HM, Gelfand EW (1980) The expression of deoxyguanosine toxicity in T lymphocytes at different stages of maturation. J Immunol 125:1578–1582PubMedGoogle Scholar
  77. 77.
    Comans-Bitter WM, de Groot R, van den Beemd R, Neijens HJ, Hop WC, Groeneveld K, Hooijkaas H, van Dongen JJ (1997) Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J Pediatr 130:388–393PubMedCrossRefGoogle Scholar
  78. 78.
    Conley ME, Lavoie A, Briggs C, Brown P, Guerra C, Puck JM (1988) Nonrandom X chromosome inactivation in B cells from carriers of X chromosome-linked severe combined immunodeficiency. Proc Natl Acad Sci USA 85:3090–3094PubMedCrossRefGoogle Scholar
  79. 79.
    Corneo B, Moshous D, Gungor T, Wulffraat N, Philippet P, Le Deist FL, Fischer A, de Villartay JP (2001) Identical mutations in RAG1 or RAG2 genes leading to defective V(D) J recombinase activity can cause either T-B-severe combined immune deficiency or Omenn syndrome. Blood 97:2772–2776PubMedCrossRefGoogle Scholar
  80. 80.
    Critchlow SE, Bowater RP, Jackson SP (1997) Mammalian DNA double-strand break repair protein XRCC4 interacts with DNA ligase IV. Curr Biol 7:588–598PubMedCrossRefGoogle Scholar
  81. 81.
    Cunningham-Rundles C, Murray HW, Smith JP (1999) Treatment of idiopathic CD4 T lymphocytopenia with IL-2. Clin Exp Immunol 116:322–325PubMedCrossRefGoogle Scholar
  82. 82.
    Dadi HK, Simon AJ, Roifman CM (2003) Effect of CD3delta deficiency on maturation of alpha/beta and gamma/delta T cell-lineages in severe combined immunodeficiency. N Engl J Med 349:1821–1828PubMedCrossRefGoogle Scholar
  83. 83.
    Dai Y, Kysela B, Hanakahi LA, Manolis K, Riballo E, Stumm M, Harville TO, West SC, Oettinger MA, Jeggo PA (2003) Nonhomologous end joining and V(D) J recombination require an additional factor. Proc Natl Acad Sci USA 100:2462–2467PubMedCrossRefGoogle Scholar
  84. 84.
    Dalal I, Grunebaum E, Cohen A, Roifman CM (2001) Two novel mutations in a purine nucleoside phosphorylase (PNP)-deficient patient. Clin Genet 59:430–437PubMedCrossRefGoogle Scholar
  85. 85.
    Danielian S, Oleastro M, Eva Rivas M, Cantisano C, Zelazko M (2007) Clinical follow-up of 11 Argentinian CD40L-deficient patients with 7 unique mutations including the so-called “milder” mutants. J Clin Immunol 27:455–459PubMedCrossRefGoogle Scholar
  86. 86.
    de la Calle-Martin O, Hernandez M, Ordi J, Casamitjana N, Arostegui JI, Caragol I, Ferrando M, Labrador M, Rodriguez-Sanchez JL, Espanol T (2001) Familial CD8 deficiency due to a mutation in the CD8 alpha gene. J Clin Invest 108:117–123PubMedGoogle Scholar
  87. 87.
    de la Salle H, Hanau D (2006) Peptide transporter defects in human leukocyte antigen Class I antigen. In: Ochs H, Smith C, Puck J (eds) Primary Immunodeficiency diseases: a molecular and genetic approach, 2 edn. Oxford University Press, New York, pp 242–250Google Scholar
  88. 88.
    de la Salle H, Hanau D, Fricker D, Urlacher A, Kelly A, Salamero J, Powis SH, Donato L, Bausinger H, Laforet M, et al. (1994) Homozygous human TAP peptide transporter mutation in HLA class I deficiency. Science 265:237–241PubMedCrossRefGoogle Scholar
  89. 89.
    de la Salle H, Houssaint E, Peyrat MA, Arnold D, Salamero J, Pinczon D, Stevanovic S, Bausinger H, Fricker D, Gomard E, Biddison W, Lehner P, UytdeHaag F, Sasportes M, Donato L, Rammensee HG, Cazenave JP, Hanau D, Tongio MM, Bonneville M (1997) Human peptide transporter deficiency: importance of HLA-B in the presentation of TAP-independent EBV antigens. J Immunol 158:4555–4563PubMedGoogle Scholar
  90. 90.
    de la Salle H, Saulquin X, Mansour I, Klayme S, Fricker D, Zimmer J, Cazenave JP, Hanau D, Bonneville M, Houssaint E, Lefranc G, Naman R (2002) Asymptomatic deficiency in the peptide transporter associated to antigen processing (TAP). Clin Exp Immunol 128:525–531PubMedCrossRefGoogle Scholar
  91. 91.
    de la Salle H, Zimmer J, Fricker D, Angenieux C, Cazenave JP, Okubo M, Maeda H, Plebani A, Tongio MM, Dormoy A, Hanau D (1999) HLA class I deficiencies due to mutations in subunit 1 of the peptide transporter TAP1. J Clin Invest 103:R9–R13PubMedCrossRefGoogle Scholar
  92. 92.
    de Saint-Basile G, Le Deist F, de Villartay JP, Cerf-Bensussan N, Journet O, Brousse N, Griscelli C, Fischer A (1991) Restricted heterogeneity of T lymphocytes in combined immunodeficiency with hypereosinophilia (Omenn’s syndrome). J Clin Invest 87:1352–1359PubMedCrossRefGoogle Scholar
  93. 93.
    de Saint Basile G, Arveiler B, Oberlé J, Malcom S, Levinsky R, Lau Y, Hofker M, Debré M, Fischer A, Griscelli C, Mandel J-L (1987) Close linkage of the locus for X chromosome-linked SCID to polymorphic markers in Xq11–q13. Proc Natl Acad Sci USA 84:7576–7579PubMedCrossRefGoogle Scholar
  94. 94.
    de Saint Basile G, Geissmann F, Flori E, Uring-Lambert B, Soudais C, Cavazzana-Calvo M, Durandy A, Jabado N, Fischer A, Le Deist F (2004) Severe combined immunodeficiency caused by deficiency in either the delta or the epsilon subunit of CD3. J Clin Invest 114:1512–1517PubMedGoogle Scholar
  95. 95.
    de Saint Basile G, Tabone MD, Durandy A, Phan F, Fischer A, Le Deist F (1999) CD40 ligand expression deficiency in a female carrier of the X-linked hyper-IgM syndrome as a result of X chromosome lyonization. Eur J Immunol 29:367–373PubMedCrossRefGoogle Scholar
  96. 96.
    de Villartay JP, Lim A, Al-Mousa H, Dupont S, Dechanet-Merville J, Coumau-Gatbois E, Gougeon ML, Lemainque A, Eidenschenk C, Jouanguy E, Abel L, Casanova JL, Fischer A, Le Deist F (2005) A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection. J Clin Invest 115:3291–3299PubMedCrossRefGoogle Scholar
  97. 97.
    de VO, Seynhaeve V (1959) Reticular dysgenesia. Lancet 2:1123–1125Google Scholar
  98. 98.
    de Vries E, de Bruin-Versteeg S, Comans-Bitter WM, de Groot R, Hop WC, Boerma GJ, Lotgering FK, van Dongen JJ (2000) Longitudinal survey of lymphocyte subpopulations in the first year of life. Pediatr Res 47:528–537PubMedCrossRefGoogle Scholar
  99. 99.
    Delicou S, Kitra-Roussou V, Peristeri J, Goussetis E, Vessalas G, Rigatou E, Psychou F, Salavoura K, Grafakos S (2007) Successful HLA-identical hematopoietic stem cell transplantation in a patient with purine nucleoside phosphorylase deficiency. Pediatr Transplant 11:799–803PubMedCrossRefGoogle Scholar
  100. 100.
    DiSanto JP, Bonnefoy JY, Gauchat JF, Fischer A, de Saint Basile G (1993) CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM. Nature 361:541–543PubMedCrossRefGoogle Scholar
  101. 101.
    DiSanto JP, Markiewicz S, Gauchat JF, Bonnefoy JY, Fischer A, de Saint Basile G (1994) Brief report: prenatal diagnosis of X-linked hyper-IgM syndrome. N Engl J Med 330:969–973PubMedCrossRefGoogle Scholar
  102. 102.
    DiSanto JP, Muller W, Guy-Grand D, Fischer A, Rajewsky K (1995) Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. Proc Natl Acad Sci USA 92:377–381PubMedCrossRefGoogle Scholar
  103. 103.
    DiSanto JP, Rieux-Laucat F, Dautry-Varsat A, Fischer A, de Saint Basile G (1994) Defective interleukine 2 receptor gamma chain in an atypical X chromosome-linked severe combined immunodeficiency with peripheral T cells. Proc Natl Acad Sci USA 91:9466–9470PubMedCrossRefGoogle Scholar
  104. 104.
    Dogu F, Ikinciogullari A, Fricker D, Bozdogan G, Aytekin C, Ileri M, Tezic T, Babacan E, De La Salle H (2006) A novel mutation for TAP deficiency and its possible association with Toxoplasmosis. Parasitol Int 55:219–222PubMedCrossRefGoogle Scholar
  105. 105.
    Donato L, de la Salle H, Hanau D, Tongio M, Oswald M, Vandevenne A, Geisert J (1995) Association of HLA class I antigen deficiency related to TAP2 gene mutation with familial bronchiectasis. J Pediatr 127:895–900PubMedCrossRefGoogle Scholar
  106. 106.
    Douek DC, Vescio RA, Betts MR, Brencheley JM, Hill BJ, Zhang L (2000) Assessment of thymic output in adults after haematopoetic stem cell transplantation and prediction of T cell reconstitution. Lancet 355:1875–1881PubMedCrossRefGoogle Scholar
  107. 107.
    Douhan J, 3rd, Hauber I, Eibl MM, Glimcher LH (1996) Genetic evidence for a new type of major histocompatibility complex class II combined immunodeficiency characterized by a dyscoordinate regulation of HLA-D alpha and beta chains. J Exp Med 183:1063–1069PubMedCrossRefGoogle Scholar
  108. 108.
    Dror Y, Grunebaum E, Hitzler J, Narendran A, Ye C, Tellier R, Edwards V, Freedman MH, Roifman CM (2004) Purine nucleoside phosphorylase deficiency associated with a dysplastic marrow morphology. Pediatr Res 55:472–477PubMedCrossRefGoogle Scholar
  109. 109.
    Drouet J, Frit P, Delteil C, de Villartay JP, Salles B, Calsou P (2006) Interplay between Ku, Artemis, and the DNA-dependent protein kinase catalytic subunit at DNA ends. J Biol Chem 281:27784–27793PubMedCrossRefGoogle Scholar
  110. 110.
    Dumoutier L, Van Roost E, Colau D, Renauld JC (2000) Human interleukin-10-related T cell-derived inducible factor. molecular cloning nad functional characterization as an hepatocyte-stimulating factor. Proc Natl Acad Sci USA 97:10144–10149PubMedCrossRefGoogle Scholar
  111. 111.
    Duncan RA, von Reyn CF, Alliegro GM, Toossi Z, Sugar AM, Levitz SM (1993) Idiopathic CD4+ T-lymphocytopenia–four patients with opportunistic infections and no evidence of HIV infection [see comments]. N Engl J Med 328:393–398PubMedCrossRefGoogle Scholar
  112. 112.
    Durand B, Sperisen P, Emery P, Barras E, Zufferey M, Mach B, Reith W (1997) RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency. Embo J 16:1045–1055PubMedCrossRefGoogle Scholar
  113. 113.
    Edwards NL (1985) Immunodeficiencies associated with errors in purine metabolism. Med Clin North Am 69:505–518PubMedGoogle Scholar
  114. 114.
    Ege M, Ma Y, Manfras B, Kalwak K, Lu H, Lieber MR, Schwarz K, Pannicke U (2005) Omenn syndrome due to ARTEMIS mutations. Blood 105:4179–4186PubMedCrossRefGoogle Scholar
  115. 115.
    Ehl S, Schwarz K, Enders A, Duffner U, Pannicke U, Kuhr J, Mascart F, Schmitt-Graef A, Niemeyer C, Fisch P (2005) A variant of SCID with specific immune responses and predominance of gamma delta T cells. J Clin Invest 115:3140–3148PubMedCrossRefGoogle Scholar
  116. 116.
    Elder ME (1997) SCID due to ZAP-70 deficiency. J Pediatr Hematol Oncol 19:546–550PubMedCrossRefGoogle Scholar
  117. 117.
    Elder ME, Lin D, Clever J, Chan AC, Hope TJ, Weiss A, Parslow TG (1994) Human severe combined immunodeficiency due to a defect in ZAP-70, a T cell tyrosine kinase. Science 264:1596–1599PubMedCrossRefGoogle Scholar
  118. 118.
    Elder ME, Skoda-Smith S, Kadlecek TA, Wang F, Wu J, Weiss A (2001) Distinct T cell developmental consequences in humans and mice expressing identical mutations in the DLAARN motif of ZAP-70. J Immunol 166:656–661PubMedGoogle Scholar
  119. 119.
    Elhasid R, Etzioni A (1996) Major histocompatibility complex class II deficiency: a clinical review. Blood Rev 10:242–248PubMedCrossRefGoogle Scholar
  120. 120.
    Elledge SJ, Zhou Z, Allen JB, Navas TA (1993) DNA damage and cell cycle regulation of ribonucleotide reductase. Bioessays 15:333–339PubMedCrossRefGoogle Scholar
  121. 121.
    Enders A, Fisch P, Schwarz K, Duffner U, Pannicke U, Nikolopoulos E, Peters A, Orlowska-Volk M, Schindler D, Friedrich W, Selle B, Niemeyer C, Ehl S (2006) A severe form of human combined immunodeficiency due to mutations in DNA ligase IV. J Immunol 176:5060–5068PubMedGoogle Scholar
  122. 122.
    Eriksson S, Arner E, Spasokoukotskaja T, Wang L, Karlsson A, Brosjo O, Gunven P, Julusson G, Liliemark J (1994) Properties and levels of deoxynucleoside kinases in normal and tumor cells; implications for chemotherapy. Adv Enzyme Regul 34:13–25PubMedCrossRefGoogle Scholar
  123. 123.
    Etzioni A, Ochs HD (2004) The hyper IgM syndrome–an evolving story. Pediatr Res 56:519–525PubMedCrossRefGoogle Scholar
  124. 124.
    Feldman GM, Rosenthal LA, Liu X, Hayes MP, Wynshaw-Boris A, Leonard WJ, Hennighausen L, Finbloom DS (1997) STAT5A-deficient mice demonstrate a defect in granulocyte-macrophage colony-stimulating factor-induced proliferation and gene expression. Blood 90:1768–1776PubMedGoogle Scholar
  125. 125.
    Ferrari S, Giliani S, Insalaco A, Al-Ghonaium A, Soresina AR, Loubser M, Avanzini MA, Marconi M, Badolato R, Ugazio AG, Levy Y, Catalan N, Durandy A, Tbakhi A, Notarangelo LD, Plebani A (2001) Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc Natl Acad Sci USA 98:12614–12619PubMedCrossRefGoogle Scholar
  126. 126.
    Ferrari S, Plebani A (2002) Cross-talk between CD40 and CD40L: lessons from primary immune deficiencies. Curr Opin Allergy Clin Immunol 2:489–494PubMedCrossRefGoogle Scholar
  127. 127.
    Feske S (2007) Calcium signalling in lymphocyte activation and disease. Nat Rev Immunol 7:690–702PubMedCrossRefGoogle Scholar
  128. 128.
    Feske S, Draeger R, Peter HH, Rao A (2000) Impaired NFAT regulation and its role in a severe combined immunodeficiency. Immunobiology 202:134–150PubMedGoogle Scholar
  129. 129.
    Feske S, Giltnane J, Dolmetsch R, Staudt LM, Rao A (2001) Gene regulation mediated by calcium signals in T lymphocytes. Nat Immunol 2:316–324PubMedCrossRefGoogle Scholar
  130. 130.
    Feske S, Gwack Y, Prakriya M, Srikanth S, Puppel SH, Tanasa B, Hogan PG, Lewis RS, Daly M, Rao A (2006) A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 441:179–185PubMedCrossRefGoogle Scholar
  131. 131.
    Feske S, Muller JM, Graf D, Kroczek RA, Drager R, Niemeyer C, Baeuerle PA, Peter HH, Schlesier M (1996) Severe combined immunodeficiency due to defective binding of the nuclear factor of activated T cells in T lymphocytes of two male siblings. Eur J Immunol 26:2119–2126PubMedCrossRefGoogle Scholar
  132. 132.
    Fierro MT, Savoia P, Quaglino P, Novero D, Bernengo MG (2005) Disseminated Kaposi’s sarcoma associated with idiopathic CD4+ lymphocytopenia and low dose steroid therapy. Clin Exp Dermatol 30:395–397PubMedCrossRefGoogle Scholar
  133. 133.
    Fischer A (2007) Human primary immunodeficiency diseases. Immunity 27:835–845PubMedCrossRefGoogle Scholar
  134. 134.
    Fischer A, Cavazzana-Calvo M, De Saint Basile G, DeVillartay JP, Di Santo JP, Hivroz C, Rieux-Laucat F, Le Deist F (1997) Naturally occurring primary deficiencies of the immune system. Annu Rev Immunol 15:93–124PubMedCrossRefGoogle Scholar
  135. 135.
    Fischer A, de Saint Basile G, Le Deist F (2005) CD3 deficiencies. Curr Opin Allergy Clin Immunol 5:491–495PubMedCrossRefGoogle Scholar
  136. 136.
    Fischer A, Landais P, Friedrich W, Gerritsen B, Fasth A, Porta F, Vellodi A, Benkerrou M, Jais JP, Cavazzana-Calvo M, et al. (1994) Bone marrow transplantation (BMT) in Europe for primary immunodeficiencies other than severe combined immunodeficiency: a report from the European Group for BMT and the European Group for Immunodeficiency. Blood 83:1149–1154PubMedGoogle Scholar
  137. 137.
    Fischer A, Malissen B (1998) Natural and engineered disorders of lymphocyte development. Science 280:237–243PubMedCrossRefGoogle Scholar
  138. 138.
    Flake AW, Roncarolo MG, Puck JM, Almeida-Porada G, Evans MI, Johnson MP, Abella EM, Harrison DD, Zanjani ED (1996) Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow. N Engl J Med 335:1806–1810PubMedCrossRefGoogle Scholar
  139. 139.
    Fleischman A, Hershfield MS, Toutain S, Lederman HM, Sullivan KE, Fasano MB, Greene J, Winkelstein JA (1998) Adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency in common variable immunodeficiency. Clin Diagn Lab Immunol 5:399–400PubMedGoogle Scholar
  140. 140.
    Fontana S, Moratto D, Mangal S, De Francesco M, Vermi W, Ferrari S, Facchetti F, Kutukculer N, Fiorini C, Duse M, Das PK, Notarangelo LD, Plebani A, Badolato R (2003) Functional defects of dendritic cells in patients with CD40 deficiency. Blood 102:4099–4106PubMedCrossRefGoogle Scholar
  141. 141.
    Fontenot JD, Gavin MA, Rudensky AY (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4:330–336PubMedCrossRefGoogle Scholar
  142. 142.
    Frank J, Pignata C, Panteleyev AA, Prowse DM, Baden H, Weiner L, Gaetaniello L, Ahmad W, Pozzi N, Cserhalmi-Friedman PB, Aita VM, Uyttendaele H, Gordon D, Ott J, Brissette JL, Christiano AM (1999) Exposing the human nude phenotype. Nature 398:473–474PubMedCrossRefGoogle Scholar
  143. 143.
    Frank KM, Sekiguchi JM, Seidl KJ, Swat W, Rathbun GA, Cheng HL, Davidson L, Kangaloo L, Alt FW (1998) Late embryonic lethality and impaired V(D) J recombination in mice lacking DNA ligase IV. Nature 396:173–177PubMedCrossRefGoogle Scholar
  144. 144.
    Fruhwirth M, Clodi K, Heitger A, Neu N (2001) Lymphocyte diversity in a 9-year-old boy with idiopathic CD4+ T cell lymphocytopenia. Int Arch Allergy Immunol 125:80–85PubMedCrossRefGoogle Scholar
  145. 145.
    Fuleihan R, Ramesh N, Loh R, Jabara H, Rosen RS, Chatila T, Fu SM, Stamenkovic I, Geha RS (1993) Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc Natl Acad Sci USA 90:2170–2173PubMedCrossRefGoogle Scholar
  146. 146.
    Furukawa H, Murata S, Yabe T, Shimbara N, Keicho N, Kashiwase K, Watanabe K, Ishikawa Y, Akaza T, Tadokoro K, Tohma S, Inoue T, Tokunaga K, Yamamoto K, Tanaka K, Juji T (1999) Splice acceptor site mutation of the transporter associated with antigen processing-1 gene in human bare lymphocyte syndrome. J Clin Invest 103:755–758PubMedCrossRefGoogle Scholar
  147. 147.
    Gadola SD, Moins-Teisserenc HT, Trowsdale J, Gross WL, Cerundolo V (2000) TAP deficiency syndrome. Clin Exp Immunol 121:173–178PubMedCrossRefGoogle Scholar
  148. 148.
    Gao Y, Sun Y, Frank KM, Dikkes P, Fujiwara Y, Seidl KJ, Sekiguchi JM, Rathbun GA, Swat W, Wang J, Bronson RT, Malynn BA, Bryans M, Zhu C, Chaudhuri J, Davidson L, Ferrini R, Stamato T, Orkin SH, Greenberg ME, Alt FW (1998) A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis. Cell 95:891–902PubMedCrossRefGoogle Scholar
  149. 149.
    Gaspar HB, Parsley KL, Howe S, King D, Gilmour KC, Sinclair J, Brouns G, Schmidt M, von Kalle C, Barington T, Jakobsen MA, Christensen HO, Al Ghonaium A, White HN, Smith JL, Levinsky RJ, Ali RR, Kinnon C, Thrasher AJ (2004) Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. Lancet 364:2181–2187PubMedCrossRefGoogle Scholar
  150. 150.
    Gatti RA, Meuwissen HJ, Allen HD, Hong R, Good RA (1968) Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet 2:1366–1369PubMedCrossRefGoogle Scholar
  151. 151.
    Gebert CA, Park SH, Waxman DJ (1997) Regulation of signal transducer and activator of transcription (STAT) 5b activation by the temporal pattern of growth hormone stimulation. Mol Endocrinol 11:400–414PubMedCrossRefGoogle Scholar
  152. 152.
    Geha RS, Notarangelo LD, Casanova JL, Chapel H, Conley ME, Fischer A, Hammarstrom L, Nonoyama S, Ochs HD, Puck JM, Roifman C, Seger R, Wedgwood J (2007) Primary immunodeficiency diseases: an update from the international Union of Immunological Societies Primary Immunodeficeincy Diseases Classification Committee. J Allergy Clin Immunol 120:776–794PubMedCrossRefGoogle Scholar
  153. 153.
    Gelfand EW, Weinberg K, Mazer BD, Kadlecek TA, Weiss A (1995) Absence of ZAP-70 prevents signaling through the antigen receptor on peripheral blood T cells but not on thymocytes. J Exp Med 182:1057–1065PubMedCrossRefGoogle Scholar
  154. 154.
    Gellert M (2002) V(D) J recombination: RAG proteins, repair factors, and regulation. Annu Rev Biochem 71:101–132PubMedCrossRefGoogle Scholar
  155. 155.
    Gennery AR (2006) Primary Immunodeficiency syndromes associated with defective DNA double-strand break repair. Br Med Bull 77 and 78:71–85PubMedCrossRefGoogle Scholar
  156. 156.
    Gennery AR, Hodges E, Williams AP, Harris S, Villa A, Angus B, Cant AJ, Smith JL (2005) Omenn’s syndrome occurring in patients without mutations in recombination activating genes. Clin Immunol 116:246–256PubMedCrossRefGoogle Scholar
  157. 157.
    Gennery AR, Khawaja K, Veys P, Bredius RG, Notarangelo LD, Mazzolari E, Fischer A, Landais P, Cavazzana-Calvo M, Friedrich W, Fasth A, Wulffraat NM, Matthes-Martin S, Bensoussan D, Bordigoni P, Lange A, Pagliuca A, Andolina M, Cant AJ, Davies EG (2004) Treatment of CD40 ligand deficiency by hematopoietic stem cell transplantation: a survey of the European experience, 1993–2002. Blood 103:1152–1157PubMedCrossRefGoogle Scholar
  158. 158.
    Giblett ER, Ammann AJ, Wara DW, Sandman R, Diamond LK (1975) Nucleoside-phosphorylase deficiency in a child with severely defective T cell immunity and normal B cell immunity. Lancet 1:1010–1013PubMedCrossRefGoogle Scholar
  159. 159.
    Giblett ER, Anderson JE, Cohen F, Pollara B, Meuwissen HJ (1972) Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. Lancet 2:1067–1069PubMedCrossRefGoogle Scholar
  160. 160.
    Gilfillan S, Dierich A, Lemeur M, Benoist C, Mathis D (1993) Mice lacking TdT: mature animals with an immature lymphocyte repertoire. Science 261:1175–1178PubMedCrossRefGoogle Scholar
  161. 161.
    Giliani S, Mori L, de Saint Basile G, Le Deist F, Rodriguez-Perez C, Forino C, Mazzolari E, Dupuis S, Elhasid R, Kessel A, Galambrun C, Gil J, Fischer A, Etzioni A, Notarangelo LD (2005) Interleukin-7 receptor alpha (IL-7Ralpha) deficiency: cellular and molecular bases. Analysis of clinical, immunological, and molecular features in 16 novel patients. Immunol Rev 203:110–126PubMedCrossRefGoogle Scholar
  162. 162.
    Glanzmann E, Riniker P (1950) Essentielle lymphocytophtose. Ein neues Krankheitsbild aus der S1uglingspathologie. Ann Paediatr 174:1–5Google Scholar
  163. 163.
    Goda S, Quale AC, Woods ML, Felthauser A, Shimizu Y (2004) Control of TCR-mediated activation of beta 1 integrins by the ZAP-70 tyrosine kinase interdomain B region and the linker for activation of T cells adapter protein. J Immunol 172:5379–5387PubMedGoogle Scholar
  164. 164.
    Goldman FD, Ballas ZK, Schutte BC, Kemp J, Hollenback C, Noraz N, Taylor N (1998) Defective expression of p56lck in an infant with severe combined immunodeficiency. J Clin Invest 102:421–429PubMedCrossRefGoogle Scholar
  165. 165.
    Gonczy P, Reith W, Barras E, Lisowska-Grospierre B, Griscelli C, Hadam MR, Mach B (1989) Inherited immunodeficiency with a defect in a major histocompatibility complex class II promoter-binding protein differs in the chromatin structure of the HLA-DRA gene. Mol Cell Biol 9:296–302PubMedGoogle Scholar
  166. 166.
    Grawunder U, Wilm M, Wu X, Kulesza P, Wilson TE, Mann M, Lieber MR (1997) Activity of DNA ligase IV stimulated by complex formation with XRCC4 protein in mammalian cells. Nature 388:492–495PubMedCrossRefGoogle Scholar
  167. 167.
    Grawunder U, Zimmer D, Fugmann S, Schwarz K, Lieber MR (1998) DNA ligase IV is essential for V(D) J recombination and DNA double-strand break repair in human precursor lymphocytes. Mol Cell 2:477–484PubMedCrossRefGoogle Scholar
  168. 168.
    Griscelli C, Lisowska-Grospierre B, Mach B (1989) Combined immunodeficiency with defective expression in MHC class II genes. Immunodefic Rev 1:135–153PubMedGoogle Scholar
  169. 169.
    Gruhn B, Seidel J, Zintl F, Varon R, T&$$$;nnies H, Neitzel H, Bechtold A, Hoehn H, Schindler D (2007) Successful bone marrow transplantation in a patient with DNA ligase IV deficiency and bone marrow failure. Orphanet J Rare Dis 2:5PubMedCrossRefGoogle Scholar
  170. 170.
    Grusby MJ, Johnson RS, Papaioannou VE, Glimcher LH (1991) Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice. Science 253:1417–1420PubMedCrossRefGoogle Scholar
  171. 171.
    Gudas LJ, Ullman B, Cohen A, Martin DW, Jr. (1978) Deoxyguanosine toxicity in a mouse T lymphoma: relationship to purine nucleoside phosphorylase-associated immune dysfunction. Cell 14:531–538PubMedCrossRefGoogle Scholar
  172. 172.
    Guilloton L, Drouet A, Bernard P, Berbineau A, Berger F, Kopp N, Ribot C (1999) [Cerebral intravascular lymphoma during T CD4+ idiopathic lymphopenia syndrome]. Presse Med 28:1513–1515PubMedGoogle Scholar
  173. 173.
    Gwack Y, Srikanth S, Feske S, Cruz-Guilloty F, Oh-hora M, Neems DS, Hogan PG, Rao A (2007) Biochemical and functional characterization of Orai proteins. J Biol Chem 282:16232–16243PubMedCrossRefGoogle Scholar
  174. 174.
    Habib T, Nelson A, Kaushansky K (2003) IL-21: a novel IL-2 family lymphokine that modulates B, T, and natural killer cell responses. J Allergy Clin Immunol 112:1033–1045PubMedCrossRefGoogle Scholar
  175. 175.
    Hacein-Bey-Abina S, Le Deist F, Carlier F, Bouneaud C, Hue C, De Villartay JP, Thrasher AJ, Wulffraat N, Sorensen R, Dupuis-Girod S, Fischer A, Davies EG, Kuis W, Leiva L, Cavazzana-Calvo M (2002) Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med 346:1185–1193PubMedCrossRefGoogle Scholar
  176. 176.
    Hacein-Bey-Abina S, von Kalle C, Schmidt M, Le Deist F, Wulffraat N, McIntyre E, Radford I, Villeval JL, Fraser CC, Cavazzana-Calvo M, Fischer A (2003) A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 348:255–256PubMedCrossRefGoogle Scholar
  177. 177.
    Hacein-Bey-Abina S, von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P, Lim A, Osborne CS, Pawliuk R, Morillon E, Sorensen R, Forster A, Fraser P, Cohen JI, de Saint Basile G, Alexander I, Wintergerst U, Frebourg T, Aurias A, Stoppa-Lyonnet D, Romana S, Radford-Weiss I, Gross F, Valensi F, Delabesse E, Macintyre E, Sigaux F, Soulier J, Leiva LE, Wissler M, Prinz C, Rabbitts TH, Le Deist F, Fischer A, Cavazzana-Calvo M (2003) LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCPI-X1. Science 302:415–419PubMedCrossRefGoogle Scholar
  178. 178.
    Haddad E, Landais P, Friedrich W, Gerritsen B, Cavazzana-Calvo M, Morgan G, Bertrand Y, Fasth A, Porta F, Cant A, Espanol T, Muller S, Veys P, Vossen J, Fischer A (1998) Long-term immune reconstitution and outcome after HLA-nonidentical T cell-depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients. Blood 91:3646–3653PubMedGoogle Scholar
  179. 179.
    Hafler DA, Compston A, Sawcer S, Lander ES, Daly MJ, De Jager PL, de Bakker PI, Gabriel SB, Mirel DB, Ivinson AJ, Pericak-Vance MA, Gregory SG, Rioux JD, McCauley JL, Haines JL, Barcellos LF, Cree B, Oksenberg JR, Hauser SL (2007) Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 357:851–862PubMedCrossRefGoogle Scholar
  180. 180.
    Hallett RJ, Cronin SM, Morgan G, Duley JA, Fairbanks LD, Simmonds HA (1994) Normal uric acid concentrations in a purine nucleoside phosphorylase (PNP) deficient child presenting with severe chicken pox, possible immunodeficiency and developmental delay. Adv Exp Med Biol 370:387–389PubMedGoogle Scholar
  181. 181.
    Han GP, Miura K, Ide Y, Tsutsui Y (2005) Genetic analysis of JC virus and BK virus from a patient with progressive multifocal leukoencephalopathy with hyper IgM syndrome. J Med Virol 76:398–405PubMedCrossRefGoogle Scholar
  182. 182.
    Hardman CM, Baker BS, Lortan J, Breuer J, Surentheran T, Powles A, Fry L (1997) Active psoriasis and profound CD4+ lymphocytopenia. Br J Dermatol 136:930–932PubMedCrossRefGoogle Scholar
  183. 183.
    Harville TO, Adams DM, Howard TA, Ware RE (1997) Oligoclonal expansion of CD45RO+ T lymphocytes in Omenn syndrome. J Clin Immunol 17:322–332PubMedCrossRefGoogle Scholar
  184. 184.
    Hauber I, Gulle H, Wolf HM, Maris M, Eggenbauer H, Eibl MM (1995) Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients. J Exp Med 181:1411–1423PubMedCrossRefGoogle Scholar
  185. 185.
    Hayward AR, Levy J, Facchetti F, Notarangelo L, Ochs HD, Etzioni A, Bonnefoy JY, Cosyns M, Weinberg A (1997) Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. J Immunol 158:977–983PubMedGoogle Scholar
  186. 186.
    Hershfield MS, Mitchell BS (1995) Immunodeficiency disease caused by adenosine deaminase and purine nucleoside deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 1725–1768Google Scholar
  187. 187.
    Hitzig W, Biro Z, Bosch H, Huser H (1958) Agammaglobulinemia and alymphocytosis with atrophy pf lymphatic tissue. Helv Paediatr Acta 13:551–585PubMedGoogle Scholar
  188. 188.
    Ho DD, Cao Y, Zhu T, Farthing C, Wang N, Gu G, Schooley RT, Daar ES (1993) Idiopathic CD4+ T-lymphocytopenia–immunodeficiency without evidence of HIV infection [see comments]. N Engl J Med 328:380–385PubMedCrossRefGoogle Scholar
  189. 189.
    Hoffman SMG, Lai KS, Tomfohrde J, Bowock A, Gordon LA, Mohrenweiser HW (1997) JAK3 maps to human chromosome 19p12 within a cluster of proto-oncogenes and transcription factors. Genomics 43:198–111CrossRefGoogle Scholar
  190. 190.
    Hori S, Takahashi T, Sakaguchi S (2003) Control of autoimmunity by naturally arising regulatory CD4+ T cells. Adv Immunol 81:331–371PubMedCrossRefGoogle Scholar
  191. 191.
    Howell RR (1996) Defects in metabolism of purines and pyrimidines. In: Nelson WE, Behrman RE, Kliejman RM (eds) Nelson textbook of pediatrics. Saunders, Philadelphia, pp 405–411Google Scholar
  192. 192.
    Hubert P, Bergeron F, Ferreira V, Seligmann M, Oksenhendler E, Debre P, Autran B (2000) Defective p56Lck activity in T cells from an adult patient with idiopathic CD4+ lymphocytopenia. Int Immunol 12:449–457PubMedCrossRefGoogle Scholar
  193. 193.
    Hubert P, Bergeron F, Grenot P, Seligman M, Krivitzky A, Debre P, Autran B (1999) [Deficiency of the CD3-TCR signal pathway in three patients with idiopathic CD4+ lymphocytopenia]. J Soc Biol 193:11–16PubMedGoogle Scholar
  194. 194.
    Hwa V, Camacho-Hubner C, Little BM, David A, Metherell LA, El-Khatib N, Savage MO, Rosenfeld RG (2007) Growth hormone insensitivity and severe short stature in siblings: a novel mutation at the exon 13-intron 13 junction of the STAT5b gene. Horm Res 68:218–224PubMedCrossRefGoogle Scholar
  195. 195.
    Hwa V, Little B, Adiyaman P, Kofoed EM, Pratt KL, Ocal G, Berberoglu M, Rosenfeld RG (2005) Severe growth hormone insensitivity resulting from total absence of signal transducer and activator of transcription 5b. J Clin Endocrinol Metab 90:4260–4266PubMedCrossRefGoogle Scholar
  196. 196.
    Hwa V, Little B, Kofoed EM, Rosenfeld RG (2004) Transcriptional regulation of insulin-like growth factor-I by interferon-gamma requires STAT-5b. J Biol Chem 279:2728–2736PubMedCrossRefGoogle Scholar
  197. 197.
    Imada K, Bloom ET, Nakajima H, Horvath-Arcidiacono JA, Udy GB, Davey HW, Leonard WJ (1998) Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activity. J Exp Med 188:2067–2074PubMedCrossRefGoogle Scholar
  198. 198.
    Imai K, Shimadzu M, Kubota T, Morio T, Matsunaga T, Park YD, Yoshioka A, Nonoyama S (2006) Female hyper IgM syndrome type 1 with a chromosomal translocation disrupting CD40LG. Biochim Biophys Acta 1762:335–340PubMedGoogle Scholar
  199. 199.
    Inhoff O, Doerries K, Doerries R, Scharf J, Groden C, Goerdt S, Schadendorf D (2007) Disseminated cutaneous Kaposi sarcoma and progressive multifocal leukoencephalopathy in a patient with idiopathic CD4+ T lymphocytopenia. Arch Dermatol 143:673–675PubMedCrossRefGoogle Scholar
  200. 200.
    Isgro A, Sirianni MC, Gramiccioni C, Mezzaroma I, Fantauzzi A, Aiuti F (2005) Idiopathic CD4+ lymphocytopenia may be due to decreased bone marrow clonogenic capability. Int Arch Allergy Immunol 136:379–384PubMedCrossRefGoogle Scholar
  201. 201.
    Ishida T, Hashimoto T, Arita M, Ito I, Osawa M (1998) Pulmonary Mycobacterium avium disease in a young patient with idiopathic CD4+ T lymphocytopenia. Intern Med 37:622–624PubMedCrossRefGoogle Scholar
  202. 202.
    Ishii J, Takeshita T, Kimura Y, Tada K, Kondo M, Nakamura M, Sugamura K (1994) Expression of the interleukin-2 (IL-2) receptor gamma chain on various populations in human peripheral blood. Int Immunol 6:1273–1277PubMedCrossRefGoogle Scholar
  203. 203.
    Jacobsohn DA, Emerick KM, Scholl P, Melin-Aldana H, O’Gorman M, Duerst R, Kletzel M (2004) Nonmyeloablative hematopoietic stem cell transplant for X-linked hyper-immunoglobulin m syndrome with cholangiopathy. Pediatrics 113:e122–127PubMedCrossRefGoogle Scholar
  204. 204.
    Jain A, Atkinson TP, Lipsky PE, Slater JE, Nelson DL, Strober W (1999) Defects of T cell effector function and post-thymic maturation in X-linked hyper-IgM syndrome. J Clin Invest 103:1151–1158PubMedCrossRefGoogle Scholar
  205. 205.
    Jenuth JP, Dilay JE, Fung E, Mably ER, Snyder FF (1991) Absence of dGTP accumulation and compensatory loss of deoxyguanosine kinase in purine nucleoside phosphorylase deficient mice. Adv Exp Med Biol 309B:273–276PubMedGoogle Scholar
  206. 206.
    Johnston JA, Bacon CM, Finbloom DS, Rees RC, Kaplan D, Shibuya K, Ortaldo JR, Gupta S, Chen YQ, Giri JD, al. e (1995) Tyrosine phosphorylation and activation of STAT5, STAT3 and Janus kinases by interleukin 2 and 15. Proc Natl Acad Sci USA 92:8705–8709PubMedCrossRefGoogle Scholar
  207. 207.
    Kale SB, Landree MA, Roth DB (2001) Conditional RAG-1 mutants block the hairpin formation step of V(D) J recombination. Mol Cell Biol 21:459–466PubMedCrossRefGoogle Scholar
  208. 208.
    Kara CJ, Glimcher LH (1993) Three in vivo promoter phenotypes in MHC class II deficient combined immunodeficiency. Immunogenetics 37:227–230PubMedCrossRefGoogle Scholar
  209. 209.
    Karpusas M, Hsu YM, Wang JH, Thompson J, Lederman S, Chess L, Thomas D (1995) 2 A crystal structure of an extracellular fragment of human CD40 ligand. Structure 3:1031–1039PubMedCrossRefGoogle Scholar
  210. 210.
    Kawamura M, McVicar DW, Johnston JA, Blake TB, Chen YQ, Lal BK, Lloyd AR, Kelvin DJ, Staples JE, Ortaldo JR, O’Shea JJ (1994) Molecular cloning of L-JAK, a Janus family protein-tyrosine kinase expressed in natural killer cells and activated leukocytes. Proc Natl Acad Sci USA 91:6374–6378PubMedCrossRefGoogle Scholar
  211. 211.
    Kazmers IS, Mitchell BS, Dadonna PE, Wotring LL, Townsend LB, Kelley WN (1981) Inhibition of purine nucleoside phosphorylase by 8-aminoguanosine: selective toxicity for T lymphoblasts. Science 214:1137–1139PubMedCrossRefGoogle Scholar
  212. 212.
    Khattri R, Cox T, Yasayko SA, Ramsdell F (2003) An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 4:337–342PubMedCrossRefGoogle Scholar
  213. 213.
    Khawaja K, Gennery AR, Flood TJ, Abinun M, Cant AJ (2001) Bone marrow transplantation for CD40 ligand deficiency: a single centre experience. Arch Dis Child 84:508–511PubMedCrossRefGoogle Scholar
  214. 214.
    Kinzler KW, Vogelstein B (1997) Cancer susceptibility genes. Gatekeepers and caretakers. Nature 386:761–763PubMedCrossRefGoogle Scholar
  215. 215.
    Kirtava Z, Blomberg J, Bredberg A, Henriksson G, Jacobsson L, Manthorpe R (1995) CD4+ T-lymphocytopenia without HIV infection: increased prevalence among patients with primary Sjogren’s syndrome. Clin Exp Rheumatol 13:609–616PubMedGoogle Scholar
  216. 216.
    Kishihara K, Penninger J, Wallace VA, Kundig TM, Kawai K, Wakeham A, Timms E, Pfeffer K, Ohashi PS, Thomas ML, et al. (1993) Normal B lymphocyte development but impaired T cell maturation in CD45-exon6 protein tyrosine phosphatase-deficient mice. Cell 74:143–156PubMedCrossRefGoogle Scholar
  217. 217.
    Klein C, Cavazzana-Calvo M, Le Deist F, Jabado N, Benkerrou M, Blanche S, Lisowska-Grospierre B, Griscelli C, Fischer A (1995) Bone marrow transplantation in major histocompatibility complex class II deficiency: a single-center study of 19 patients. Blood 85:580–587PubMedGoogle Scholar
  218. 218.
    Klein C, Lisowska-Grospierre B, LeDeist F, Fischer A, Griscelli C (1993) Major histocompatibility complex class II deficiency: clinical manifestations, immunologic features, and outcome. J Pediatr 123:921–928PubMedCrossRefGoogle Scholar
  219. 219.
    Koch J, Tampe R (2006) The macromolecular peptide-loading complex in MHC class I-dependent antigen presentation. Cell Mol Life Sci 63:653–662PubMedCrossRefGoogle Scholar
  220. 220.
    Kofoed EM, Hwa V, Little B, Woods KA, Buckway CK, Tsubaki J, Pratt KL, Bezrodnik L, Jasper H, Tepper A, Heinrich JJ, Rosenfeld RG (2003) Growth hormone insensitivity associated with a STAT5b mutation. N Engl J Med 349:1139–1147PubMedCrossRefGoogle Scholar
  221. 221.
    Komori T, Okada A, Stewart V, Alt FW (1993) Lack of N regions in antigen receptor variable region genes of TdT-deficient lymphocytes. Science 261:1171–1175PubMedCrossRefGoogle Scholar
  222. 222.
    Korthauer U, Graf D, Mages HW, Briere F, Padayachee M, Malcolm S, Ugazio AG, Notarangelo LD, Levinsky RJ, Kroczek RA (1993) Defective expression of T cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361:539–541PubMedCrossRefGoogle Scholar
  223. 223.
    Krawczyk M, Reith W (2006) Regulation of MHC class II expression, a unique regulatory system identified by the study of a primary immunodeficiency disease. Tissue Antigens 67:183–197PubMedCrossRefGoogle Scholar
  224. 224.
    Kumaki S, Ochs HD, Timour M, Schooley K, Ahdieh M, Hill H, Sugamura K, Anderson D, Zhu Q, Cosman K, Giri JG (1995) Characterization of B cell lines established from two X-linked severe combined immunodeficiency patients: interleukin-15 binds to the B cells but is not internalized efficiently. Blood 86:1428–1436PubMedGoogle Scholar
  225. 225.
    Kumaki S, Villa A, Asada H, Kawai S, Ohashi Y, Takahashi M, Hakozaki I, Nitanai E, Minegishi M, Tsuchiya S (2001) Identification of anti-herpes simplex virus antibody-producing B cells in a patient with an atypical RAG1 immunodeficiency. Blood 98:1464–1468PubMedCrossRefGoogle Scholar
  226. 226.
    Kumlin U, Elmqvist LG, Granlund M, Olsen B, Tarnvik A (1997) CD4 lymphopenia in a patient with cryptococcal osteomyelitis. Scand J Infect Dis 29:205–206PubMedCrossRefGoogle Scholar
  227. 227.
    Kundumani-Sridharan V, Wang D, Karpurapu M, Liu Z, Zhang C, Dronadula N, Rao GN (2007) Suppression of activation of signal transducer and activator of transcription-5B signaling in the vessel wall reduces balloon injury-induced neointima formation. Am J Pathol 171:1381–1394PubMedCrossRefGoogle Scholar
  228. 228.
    Kung C, Pingel J, Heikinheimo M, Klemola T, Varkila K, Yoo LI, Vuopala K, Poyhonen M, Uhari M, Rogers M, Speck SH, Chatila T, Thomas ML (2000) Mutations inthe tyrosine phosphatase CD45 gene ina child with severe combined immunodeficiency disease. Nat Med 6:343–345PubMedCrossRefGoogle Scholar
  229. 229.
    Kutukculer N, Aksoylar S, Kansoy S, Cetingul N, Notarangelo LD (2003) Outcome of hematopoietic stem cell transplantation in hyper-IgM syndrome caused by CD40 deficiency. J Pediatr 143:141–142PubMedCrossRefGoogle Scholar
  230. 230.
    Kutukculer N, Moratto D, Aydinok Y, Lougaris V, Aksoylar S, Plebani A, Genel F, Notarangelo LD (2003) Disseminated cryptosporidium infection in an infant with hyper-IgM syndrome caused by CD40 deficiency. J Pediatr 142:194–196PubMedCrossRefGoogle Scholar
  231. 231.
    Lagresle-Peyrou C, Yates F, Malassis-Seris M, Hue C, Morillon E, Garrigue A, Liu A, Hajdari P, Stockholm D, Danos O, Lemercier B, Gougeon ML, Rieux-Laucat F, de Villartay JP, Fischer A, Cavazzana-Calvo M (2006) Long-term immune reconstitution in RAG-1-deficient mice treated by retroviral gene therapy: a balance between efficiency and toxicity. Blood 107:63–72PubMedCrossRefGoogle Scholar
  232. 232.
    Lambert M, Van Eggermond M, Mascart F, Dupont E, Van den Elsen P (1992) TCR V alpha- and V beta-gene segment use in T cell subcultures derived from a type-III bare lymphocyte syndrome patient deficient in MHC class-II expression. Dev Immunol 2:227–236PubMedCrossRefGoogle Scholar
  233. 233.
    Lankat-Buttgereit B, Tampe R (2002) The transporter associated with antigen processing: function and implications in human diseases. Physiol Rev 82:187–204PubMedGoogle Scholar
  234. 234.
    Laurence J, Mitra D, Steiner M, Lynch DH, Siegal FP, Staiano-Coico L (1996) Apoptotic depletion of CD4+ T cells in idiopathic CD4+ T lymphocytopenia. J Clin Invest 97:672–680PubMedCrossRefGoogle Scholar
  235. 235.
    Le Deist F, Hivroz C, Partiseti M, Thomas C, Buc HA, Oleastro M, Belohradsky B, Choquet D, Fischer A (1995) A primary T cell immunodeficiency associated with defective transmembrane calcium influx. Blood 85:1053–1062PubMedGoogle Scholar
  236. 236.
    Le Deist F, Poinsignon C, Moshous D, Fischer A, de Villartay JP (2004) Artemis sheds new light on V(D) J recombination. Immunol Rev 200:142–155PubMedCrossRefGoogle Scholar
  237. 237.
    Lee WI, Torgerson TR, Schumacher MJ, Yel L, Zhu Q, Ochs HD (2005) Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome. Blood 105:1881–1890PubMedCrossRefGoogle Scholar
  238. 238.
    Lentino JR, Brooks D (1994) Pneumocystis carinii pneumonia and tuberculosis in an human immunodeficiency virus-seronegative patient without evidence of the idiopathic CD4+ T lymphopenia syndrome. Clin Infect Dis 18:470–471PubMedGoogle Scholar
  239. 239.
    Leonard WJ, Noguchi M, Russell SM, McBride OW (1994) The molecular basis of X-linked severe combined immunodeficiency: the role of the interleukin-2 receptor gamma chain as a common gamma chain, gamma c. Immunol Rev 138:61–86PubMedCrossRefGoogle Scholar
  240. 240.
    Levy DE, Gilliland DG (2000) Divergent roles of STAT1 and STAT5 in malignancy as revealed by gene disruptions in mice. Oncogene 19:2505–2510PubMedCrossRefGoogle Scholar
  241. 241.
    Levy J, Espanol-Boren T, Thomas C, Fischer A, Tovo P, Bordigoni P, Resnick I, Fasth A, Baer M, Gomez L, Sanders EA, Tabone MD, Plantaz D, Etzioni A, Monafo V, Abinun M, Hammarstrom L, Abrahamsen T, Jones A, Finn A, Klemola T, DeVries E, Sanal O, Peitsch MC, Notarangelo LD (1997) Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr 131:47–54PubMedCrossRefGoogle Scholar
  242. 242.
    Lewis SM (1994) P nucleotide insertions and the resolution of hairpin DNA structures in mammalian cells. Proc Natl Acad Sci USA 91:1332–1336PubMedCrossRefGoogle Scholar
  243. 243.
    Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479–489PubMedCrossRefGoogle Scholar
  244. 244.
    Li Z, Otevrel T, Gao Y, Cheng HL, Seed B, Stamato TD, Taccioli GE, Alt FW (1995) The XRCC4 gene encodes a novel protein involved in DNA double-strand break repair and V(D) J recombination. Cell 83:1079–1089PubMedCrossRefGoogle Scholar
  245. 245.
    Lieber MR, Hesse JE, Mizuuchi K, Gellert M (1988) Lymphoid V(D) J recombination: nucleotide insertion at signal joints as well as coding joints. Proc Natl Acad Sci USA 85:8588–8592PubMedCrossRefGoogle Scholar
  246. 246.
    Liou J, Kim ML, Heo WD, Jones JT, Myers JW, Ferrell JE, Jr., Meyer T (2005) STIM is a Ca2+ sensor essential for Ca2+-store-depletion-triggered Ca2+ influx. Curr Biol 15:1235–1241PubMedCrossRefGoogle Scholar
  247. 247.
    Liu X, Robinson GW, Wagner KU, Garrett L, Wynshaw-Boris A, Hennighausen L (1997) Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev 11:179–186PubMedCrossRefGoogle Scholar
  248. 248.
    Lopez-Granados E, Temmerman ST, Wu L, Reynolds JC, Follmann D, Liu S, Nelson DL, Rauch F, Jain A (2007) Osteopenia in X-linked hyper-IgM syndrome reveals a regulatory role for CD40 ligand in osteoclastogenesis. Proc Natl Acad Sci USA 104:5056–5061PubMedCrossRefGoogle Scholar
  249. 249.
    Lougaris V, Badolato R, Ferrari S, Plebani A (2005) Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features. Immunol Rev 203:48–66PubMedCrossRefGoogle Scholar
  250. 250.
    Luik RM, Wu MM, Buchanan J, Lewis RS (2006) The elementary unit of store-operated Ca2+ entry: local activation of CRAC channels by STIM1 at ER-plasma membrane junctions. J Cell Biol 174:815–825PubMedCrossRefGoogle Scholar
  251. 251.
    Lynch M, Baker E, Park LS, Sutherland GR, Goodwin RG (1992) The interleukin-7 receptor gene is at 5p13. Hum Genet 89:566–568PubMedCrossRefGoogle Scholar
  252. 252.
    Ma Y, Pannicke U, Schwarz K, Lieber MR (2002) Hairpin opening and overhang processing by an Artemis/DNA-dependent protein kinase complex in nonhomologous end joining and V(D) J recombination. Cell 108:781–794PubMedCrossRefGoogle Scholar
  253. 253.
    Macchi P, Villa A, Giliani S, Sacco MG, Frattini A, Porta F, Ugazio AG, Johnston JA, Candotti F, O’Shea JJ, Vezzoni P, Notarangelo LD (1995) Mutations of the Jak-3 gene in patients with autosomal severe combined immunodeficiency (SCPI). Nature 377:65–68PubMedCrossRefGoogle Scholar
  254. 254.
    Malaspina A, Moir S, Chaitt DG, Rehm CA, Kottilil S, Falloon J, Fauci AS (2007) Idiopathic CD4+ T lymphocytopenia is associated with increases in immature/transitional B cells and serum levels of IL-7. Blood 109:2086–2088PubMedCrossRefGoogle Scholar
  255. 255.
    Malek TR, Porter BO, He YW (1999) Multiple gamma c-dependent cytokines regulate T cell development. Immunol Today 20:71–76PubMedCrossRefGoogle Scholar
  256. 256.
    Mancebo E, Moreno-Pelayo MA, Mencia A, de la Calle-Martin O, Allende LM, Sivadorai P, Kalaydjieva L, Bertranpetit J, Coto E, Calleja-Antolin S, Ruiz-Contreras J, Paz-Artal E (2008) Gly111Ser mutation in CD8A gene causing CD8 immunodeficiency is found in Spanish Gypsies. Mol Immunol 45:479–484PubMedCrossRefGoogle Scholar
  257. 257.
    Manchado Lopez P, Ruiz de Morales JM, Ruiz Gonzalez I, Rodriguez Prieto MA (1999) Cutaneous infections by papillomavirus, herpes zoster and Candida albicans as the only manifestation of idiopathic CD4+ T lymphocytopenia. Int J Dermatol 38:119–121PubMedCrossRefGoogle Scholar
  258. 258.
    Marodi L, Notarangelo L (2007) Immunological and genetic basses of new primary immunodeficiencies. Nat Rev Immunol 7:851–861PubMedCrossRefGoogle Scholar
  259. 259.
    Masternak K, Barras E, Zufferey M, Conrad B, Corthals G, Aebersold R, Sanchez JC, Hochstrasser DF, Mach B, Reith W (1998) A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients. Nat Genet 20:273–277PubMedCrossRefGoogle Scholar
  260. 260.
    Masternak K, Muhlethaler-Mottet A, Villard J, Peretti M, Reith W (2000) Molecular genetics of the Bare lymphocyte syndrome. Rev Immunogenet 2:267–282PubMedGoogle Scholar
  261. 261.
    Matamoros N, Mila J, Llano M, Balas A, Vicario JL, Pons J, Crespi C, Martinez N, Iglesias-Alzueta J, Lopez-Botet M (2001) Molecular studies and NK cell function of a new case of TAP2 homozygous human deficiency. Clin Exp Immunol 125:274–282PubMedCrossRefGoogle Scholar
  262. 262.
    Matheux F, Ikinciogullari A, Zapata DA, Barras E, Zufferey M, Dogu F, Regueiro JR, Reith W, Villard J (2002) Direct genetic correction as a new method for diagnosis and molecular characterization of MHC class II deficiency. Mol Ther 6:824–829PubMedCrossRefGoogle Scholar
  263. 263.
    Matsuda S, Suzuki-Fujimoto T, Minowa A, Ueno H, Katamura K, Koyasu S (1999) Temperature-sensitive ZAP70 mutants degrading through a proteasome-independent pathway. Restoration of a kinase domain mutant by Cdc37. J Biol Chem 274:34515–34518PubMedCrossRefGoogle Scholar
  264. 264.
    Mazzolari E, Lanzi G, Forino C, Lanfranchi A, Aksu G, Ozturk C, Giliani S, Notarangelo LD, Kutukculer N (2007) First report of successful stem cell transplantation in a child with CD40 deficiency. Bone Marrow Transplant 40:279–281PubMedCrossRefGoogle Scholar
  265. 265.
    McBlane JF, van Gent DC, Ramsden DA, Romeo C, Cuomo CA, Gellert M, Oettinger MA (1995) Cleavage at a V(D) J recombination signal requires only RAG1 and RAG2 proteins and occurs in two steps. Cell 83:387–395PubMedCrossRefGoogle Scholar
  266. 266.
    McConkey DJ, Jondal M, Orrenius S (1994) The regulation of apoptosis in thymocytes. Biochem Soc Trans 22:606–610PubMedGoogle Scholar
  267. 267.
    McGinniss MH, Wasniowska K, Zopf DA, Straus SE, Reichert CM (1985) An erythrocyte Pr auto-antibody with sialoglycoprotein specificity in a patient with purine nucleoside phosphorylase deficiency. Transfusion 25:131–136PubMedCrossRefGoogle Scholar
  268. 268.
    Mecklenburg L, Tychsen B, Paus R (2005) Learning from nudity: lessons from the nude phenotype. Exp Dermatol 14:797–810PubMedCrossRefGoogle Scholar
  269. 269.
    Meinl E, Lengenfelder D, Blank N, Pirzer R, Barata L, Hivroz C (2000) Differential requirement of ZAP-70 for CD2-mediated activation pathways of mature human T cells. J Immunol 165:3578–3583PubMedGoogle Scholar
  270. 270.
    Mella P, Imberti L, Brugnoni D, Pirovano S, Candotti F, Mazzolari E, Bettinardi A, Fiorini M, De Mattia D, Martire B, Plebani A, Notarangelo LD, Giliani S (2000) Development of autologous T lymphocytes in two males with X-linked severe combined immune deficiency: molecular and cellular characterization. Clin Immunol 95:39–50PubMedCrossRefGoogle Scholar
  271. 271.
    Meuth M (1989) The molecular basis of mutations induced by deoxyribonucleoside triphosphate pool imbalances in mammalian cells. Exp Cell Res 181:305–316PubMedCrossRefGoogle Scholar
  272. 272.
    Minami Y, Kono T, Miyazaki T, Taniguchi T (1993) The IL-2 receptor complex: its structure, function, and target genes. Annu Rev Immunol 11:245–268PubMedCrossRefGoogle Scholar
  273. 273.
    Moallem HJ, Taningo G, Jiang CK, Hirschhorn R, Fikrig S (2002) Purine nucleoside phosphorylase deficiency: a new case report and identification of two novel mutations (Gly156A1a and Val217Ile), only one of which (Gly156A1a) is deleterious. Clin Immunol 105:75–80PubMedCrossRefGoogle Scholar
  274. 274.
    Moins-Teisserenc HT, Gadola SD, Cella M, Dunbar PR, Exley A, Blake N, Baykal C, Lambert J, Bigliardi P, Willemsen M, Jones M, Buechner S, Colonna M, Gross WL, Cerundolo V (1999) Association of a syndrome resembling Wegener’s granulomatosis with low surface expression of HLA class-I molecules. Lancet 354:1598–1603PubMedCrossRefGoogle Scholar
  275. 275.
    Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE (1992) RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68:869–877PubMedCrossRefGoogle Scholar
  276. 276.
    Moriggl R, Sexl V, Piekorz R, Topham D, Ihle JN (1999) Stat5 activation is uniquely associated with cytokine signaling in peripheral T cells. Immunity 11:225–230PubMedCrossRefGoogle Scholar
  277. 277.
    Moriggl R, Topham DJ, Teglund S, Sexl V, McKay C, Wang D, Hoffmeyer A, van Deursen J, Sangster MY, Bunting KD, Grosveld GC, Ihle JN (1999) Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity 10:249–259PubMedCrossRefGoogle Scholar
  278. 278.
    Moshous D, Callebaut I, de Chasseval R, Corneo B, Cavazzana-Calvo M, Le Deist F, Tezcan I, Sanal O, Bertrand Y, Philippe N, Fischer A, de Villartay JP (2001) Artemis, a novel DNA double-strand break repair/V(D) J recombination protein, is mutated in human severe combined immune deficiency. Cell 105:177–186PubMedCrossRefGoogle Scholar
  279. 279.
    Moshous D, Callebaut I, de Chasseval R, Poinsignon C, Villey I, Fischer A, de Villartay JP (2003) The V(D) J recombination/DNA repair factor artemis belongs to the metallo-beta-lactamase family and constitutes a critical developmental checkpoint of the lymphoid system. Ann NY Acad Sci 987:150–157PubMedCrossRefGoogle Scholar
  280. 280.
    Moshous D, Pannetier C, Chasseval Rd R, Deist Fl F, Cavazzana-Calvo M, Romana S, Macintyre E, Canioni D, Brousse N, Fischer A, Casanova JL, Villartay JP (2003) Partial T and B lymphocyte immunodeficiency and predisposition to lymphoma in patients with hypomorphic mutations in Artemis. J Clin Invest 111:381–387PubMedGoogle Scholar
  281. 281.
    Mostoslavsky G, Fabian AJ, Rooney S, Alt FW, Mulligan RC (2006) Complete correction of murine Artemis immunodeficiency by lentiviral vector-mediated gene transfer. Proc Natl Acad Sci USA 103:16406–16411PubMedCrossRefGoogle Scholar
  282. 282.
    Myers LA, Hershfield MS, Neale WT, Escolar M, Kurtzberg J (2004) Purine nucleoside phosphorylase deficiency (PNP-def) presenting with lymphopenia and developmental delay: successful correction with umbilical cord blood transplantation. J Pediatr 145:710–712PubMedCrossRefGoogle Scholar
  283. 283.
    Nagaraj N, Egwim C, Adler DG (2007) X-linked hyper-IgM syndrome associated with poorly differentiated neuroendocrine tumor presenting as obstructive jaundice secondary to extensive adenopathy. Dig Dis Sci 52:2312–2316PubMedCrossRefGoogle Scholar
  284. 284.
    Nagarajan UM, Louis-Plence P, DeSandro A, Nilsen R, Bushey A, Boss JM (1999) RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency [published erratum appears in Immunity 1999 Mar;10(3):399]. Immunity 10:153–162PubMedCrossRefGoogle Scholar
  285. 285.
    Nakajima H, Liu XW, Wynshaw-Boris A, Rosenthal LA, Imada K, Finbloom DS, Hennighausen L, Leonard WJ (1997) An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for Stat5a in IL-2-mediated IL-2 receptor alpha chain induction. Immunity 7:691–701PubMedCrossRefGoogle Scholar
  286. 286.
    Negishi I, Motoyama N, Nakayama K, Nakayama K, Senju S, Hatakeyama S, Zhang Q, Chan AC, Loh DY (1995) Essential role for ZAP-70 in both positive and negative selection of thymocytes. Nature 376:435–438PubMedCrossRefGoogle Scholar
  287. 287.
    Nehls M, Pfeifer D, Schorpp M, Hedrich H, Boehm T (1994) New member of the winged-helix protein family disrupted in mouse and rat nude mutations. Nature 372:103–107PubMedCrossRefGoogle Scholar
  288. 288.
    Nekrep N, Jabrane-Ferrat N, Wolf HM, Eibl MM, Geyer M, Peterlin BM (2002) Mutation in a winged-helix DNA-binding motif causes atypical bare lymphocyte syndrome. Nat Immunol 3:1075–1081PubMedCrossRefGoogle Scholar
  289. 289.
    Netea MG, Brouwer AE, Hoogendoorn EH, Van der Meer JW, Koolen M, Verweij PE, Kullberg BJ (2004) Two patients with cryptococcal meningitis and idiopathic CD4 lymphopenia: defective cytokine production and reversal by recombinant interferon- gamma therapy. Clin Infect Dis 39:e83–87PubMedCrossRefGoogle Scholar
  290. 290.
    Neumeister B, Zollner TM, Krieger D, Sterry W, Marre R (1995) Mycetoma due to Exophiala jeanselmei and Mycobacterium chelonae in a 73-year-old man with idiopathic CD4+ T lymphocytopenia. Mycoses 38:271–276PubMedCrossRefGoogle Scholar
  291. 291.
    Nijnik A, Woodbine L, Marchetti C, Dawson S, Lambe T, Liu C, Rodrigues NP, Crockford TL, Cabuy E, Vindigni A, Enver T, Bell JI, Slijepcevic P, Goodnow CC, Jeggo PA, Cornall RJ (2007) DNA repair is limiting for haematopoietic stem cells during ageing. Nature 447:686–690PubMedCrossRefGoogle Scholar
  292. 292.
    Noguchi M, Yi H, Rosenblatt HM, Filipovich AH, Adelstein S, Modi WS, McBride OW, Leonard WJ (1993) Interleukin-2 receptor gamma chain mutations results in X-linked severe combined immunodeficiency in humans. Cell 73:147–157PubMedCrossRefGoogle Scholar
  293. 293.
    Noordzij JG, Verkaik NS, Hartwig NG, de Groot R, van Gent DC, van Dongen JJ (2000) N-terminal truncated human RAG1 proteins can direct T cell receptor but not immunoglobulin gene rearrangements. Blood 96:203–209PubMedGoogle Scholar
  294. 294.
    Noraz N, Schwarz K, Steinberg M, Dardalhon V, Rebouissou C, Hipskind R, Friedrich W, Yssel H, Bacon K, Taylor N (2000) Alternative antigen receptor (TCR) signaling in T cells derived from ZAP-70-deficient patients expressing high levels of Syk. J Biol Chem 275:15832–15838PubMedCrossRefGoogle Scholar
  295. 295.
    Notarangelo L, Casanova JL, Conley ME, Chapel H, Fischer A, Puck J, Roifman C, Seger R, Geha RS (2006) Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee Meeting in Budapest, 2005. J Allergy Clin Immunol 117:883–896PubMedCrossRefGoogle Scholar
  296. 296.
    Notarangelo LD, Giliani S, Mazza C, Mella P, Savoldi G, Rodriguez-Perez C, Mazzolari E, Fiorini M, Duse M, Plebani A, Ugazio AG, Vihinen M, Candotti F, Schumacher RF (2000) Of genes and phenotypes: the immunological and molecular spectrum of combined immune deficiency. Defects of the gamma(c)-JAK3 signaling pathway as a model. Immunol Rev 178:39–48PubMedCrossRefGoogle Scholar
  297. 297.
    Notarangelo LD, Giliani S, Mella P, Schumacher RF, Mazza C, Savoldi G, Rodriguez-Perez C, Badolato R, Mazzolari E, Porta F, Candotti F, Ugazio AG (2000) Combined immunodeficiencies due to defects in signal transduction: defects of the gammac-JAK3 signaling pathway as a model. Immunobiology 202:106–119PubMedGoogle Scholar
  298. 298.
    Notarangelo LD, Lanzi G, Peron S, Durandy A (2006) Defects of class-switch recombination. J Allergy Clin Immunol 117:855–864PubMedCrossRefGoogle Scholar
  299. 299.
    Notarangelo LD, Mella P, Jones A, de Saint Basile G, Savoldi G, Cranston T, Vihinen M, Schumacher RF (2001) Mutations in severe combined immunodeficiency (SCID) due to JAK3 deficiency. Hum Mutat 18:225–263CrossRefGoogle Scholar
  300. 300.
    Notarangelo LD, Peitsch MC (1996) CD40lbase: a database of CD40L gene mutations causing X-linked hyper-IgM syndrome. Immunol Today 17:511–516PubMedCrossRefGoogle Scholar
  301. 301.
    Nunez MJ, de Lis JM, Rodriguez JR, Allegue MJ, Viladrich A, Conde C, Santiago MP, Amigo MC (1999) [Disseminated encephalic cryptococcosis as a form of presentation of idiopathic T-CD4 lymphocytopenia]. Rev Neurol 28:390–393PubMedGoogle Scholar
  302. 302.
    O’Driscoll M, Cerosaletti KM, Girard PM, Dai Y, Stumm M, Kysela B, Hirsch B, Gennery A, Palmer SE, Seidel J, Gatti RA, Varon R, Oettinger MA, Neitzel H, Jeggo PA, Concannon P (2001) DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol Cell 8:1175–1185PubMedCrossRefGoogle Scholar
  303. 303.
    O’Driscoll M, Jeggo PA (2006) The role of double-strand break repair - insights from human genetics. Nat Rev Genet 7:45–54PubMedCrossRefGoogle Scholar
  304. 304.
    Oettinger MA, Schatz DG, Gorka C, Baltimore D (1990) RAG-1 and RAG-2, adjacent genes that synergistically activate V(D) J recombination. Science 248:1517–1523PubMedCrossRefGoogle Scholar
  305. 305.
    Omenn GS (1965) Familial reticuloendotheliosis with eosinophilia. N Engl J Med 273:427–432PubMedGoogle Scholar
  306. 306.
    Ott MG, Schmidt M, Schwarzwaelder K, Stein S, Siler U, Koehl U, Glimm H, Kuhlcke K, Schilz A, Kunkel H, Naundorf S, Brinkmann A, Deichmann A, Fischer M, Ball C, Pilz I, Dunbar C, Du Y, Jenkins NA, Copeland NG, Luthi U, Hassan M, Thrasher AJ, Hoelzer D, von Kalle C, Seger R, Grez M (2006) Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med 12:401–409PubMedCrossRefGoogle Scholar
  307. 307.
    Ozkinay F, Pehlivan S, Onay H, van den Berg P, Vardar F, Koturoglu G, Aksu G, Unal D, Tekgul H, Can S, Ozkinay C (2007) Purine nucleoside phosphorylase deficiency in a patient with spastic paraplegia and recurrent infections. J Child Neurol 22:741–743PubMedCrossRefGoogle Scholar
  308. 308.
    Pannicke U, Tuchschmid P, Friedrich W, Bartram CR, Schwarz K (1996) Two novel missense and frameshift mutations in exons 5 and 6 of the purine nucleoside phosphorylase (PNP) gene in a severe combined immunodeficiency (SCID) patient. Hum Genet 98:706–709PubMedCrossRefGoogle Scholar
  309. 309.
    Parissiadis A, Dormoy A, Fricker D, Hanau D, de la Salle H, Cazenave JP, Lenoble P, Donato L (2005) Unilateral necrotising toxoplasmic retinochoroiditis as the main clinical manifestation of a peptide transporter (TAP) deficiency. Br J Ophthalmol 89:1661–1662PubMedCrossRefGoogle Scholar
  310. 310.
    Park I, Ives DH (1988) Properties of a highly purified mitochondrial deoxyguanosine kinase. Arch Biochem Biophys 266:51–60PubMedCrossRefGoogle Scholar
  311. 311.
    Partiseti M, Le Deist F, Hivroz C, Fischer A, Korn H, Choquet D (1994) The calcium current activated by T cell receptor and store depletion in human lymphocytes is absent in a primary immunodeficiency. J Biol Chem 269:32327–32335PubMedGoogle Scholar
  312. 312.
    Parvaneh N, Ashrafi MR, Yeganeh M, Pouladi N, Sayarifar F, Parvaneh L (2007) Progressive multifocal leukoencephalopathy in purine nucleoside phosphorylase deficiency. Brain Dev 29:124–126PubMedCrossRefGoogle Scholar
  313. 313.
    Pasic S, Minic P, Dzudovic S, Minic A, Slavkovic B (2005) Idiopathic CD4+ lymphocytopenia and juvenile laryngeal papillomatosis. Pediatr Pulmonol 39:281–283PubMedCrossRefGoogle Scholar
  314. 314.
    Payne R, Brodsky FM, Peterlin BM, Young LM (1983) “Bare lymphocytes” without immunodeficiency. Hum Immunol 6:219–227PubMedCrossRefGoogle Scholar
  315. 315.
    Pepper AE, Buckley RH, Small TN, Puck JM (1995) Two CpG mutation hot spots in the interleukin-2 receptor gamma chain causing human X-linked severe combined immunodeficiency. Am J Hum Genet 57:564–571PubMedGoogle Scholar
  316. 316.
    Perez-Aciego P, Alarcon B, Arnaiz-Villena A, Terhorst C, Timon M, Segurado OG, Regueiro JR (1991) Expression and function of a variant T cell-receptor complex lacking CD3-gamma. J Exp Med 174:318–326CrossRefGoogle Scholar
  317. 317.
    Peschon JJ, Morrissey PJ, Grabstein KH, Ramsdell FJ, Maraskovsky E, Gliniak BC, Park LS, Ziegler SF, Williams DE, Ware CB (1994) Early lymphocyte expansion is severelyimpaired in interleukin 7 receptor deficient mice. J Exp Med 180:1955PubMedCrossRefGoogle Scholar
  318. 318.
    Petersen EJ, Rozenberg-Arska M, Dekker AW, Clevers HC, Verdonck LF (1996) Allogeneic bone marrow transplantation can restore CD4+ T-lymphocyte count and immune function in idiopathic CD4+ T-lymphocytopenia. Bone Marrow Transplant 18:813–815PubMedGoogle Scholar
  319. 319.
    Pignata C, Fiore M, Guzzetta V, Castaldo A, Sebastio G, Porta F, Guarino A (1996) Congenital Alopecia and nail dystrophy associated with severe functional T cell immunodeficiency in two sibs. Am J Med Genet 65:167–170PubMedCrossRefGoogle Scholar
  320. 320.
    Pignata C, Gaetaniello L, Masci AM, Frank J, Christiano A, Matrecano E, Racioppi L (2001) Human equivalent of the mouse Nude/SCID phenotype: long-term evaluation of immunologic reconstitution after bone marrow transplantation. Blood 97:880–885PubMedCrossRefGoogle Scholar
  321. 321.
    Plebani A, Monafo V, Cattaneo R, Carella G, Brugnoni D, Facchetti F, Battocchio S, Meini A, Notarangelo LD, Duse M, Ugazio AG (1996) Defective expression of HLA class I and CD1a molecules in boy with Marfan-like phenotype and deep skin ulcers. J Am Acad Dermatol 35:814–818PubMedCrossRefGoogle Scholar
  322. 322.
    Posmantur R, Wang KK, Nath R, Gilbertsen RB (1997) A purine nucleoside phosphorylase (PNP) inhibitor induces apoptosis via caspase-3-like protease activity in MOLT-4 T cells. Immunopharmacology 37:231–244PubMedCrossRefGoogle Scholar
  323. 323.
    Puck JM, de Saint Basile G, Schwarz K, Fugmann S, Fischer RE (1996) IL2RG-base: a database of gamma c-chain defects causing human X-SCID. Immunol Today 17:507–511PubMedCrossRefGoogle Scholar
  324. 324.
    Puck JM, Deschenes SM, Porter JC, Dutra AS, Brown CJ, Willard HF, Henthorn PS (1993) The interleukin-2 receptor gamma chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1. Hum Mol Genet 2:1099–1104PubMedCrossRefGoogle Scholar
  325. 325.
    Puck JM, Stewart CC, Nussbaum RL (1992) Maximun likelihood analysis of human T cell X chromosome inactivation patterns: normal women versus carriers of X-linked severe combined immunodeficiency. Am J Hum Genet 50:742–748PubMedGoogle Scholar
  326. 326.
    Puel A, Leonard WJ (2000) Mutations in the gene for the IL-7 receptor result in T-B+NK+ severe combined immunodeficiency disease. Curr Opin Immunol 12:463–473CrossRefGoogle Scholar
  327. 327.
    Puel A, Ziegler SF, Buckley RH, Leonard WJ (1998) Defective IL7R expression in T(-) B(+) Nk(+) severe combined immunodeficiency. Nat Genet 20:394–397PubMedCrossRefGoogle Scholar
  328. 328.
    Purnell D, Ilchyshyn A, Jenkins D, Salim A, Seth R, Snead D (2001) Isolated human papillomavirus 18-positive extragenital bowenoid papulosis and idiopathic CD4+ lymphocytopenia. Br J Dermatol 144:619–621PubMedCrossRefGoogle Scholar
  329. 329.
    Qu HQ, Montpetit A, Ge B, Hudson TJ, Polychronakos C (2007) Toward further mapping of the association between the IL2RA locus and type 1 diabetes. Diabetes 56:1174–1176PubMedCrossRefGoogle Scholar
  330. 330.
    Raas U, Ahel I, West SC (2007) Defective DNA repair and neurodegenerative disease. Cell 130:991–1004CrossRefGoogle Scholar
  331. 331.
    Ram PA, Park SH, Choi HK, Waxman DJ (1996) Growth hormone activation of Stat 1, Stat 3, and Stat 5 in rat liver. Differential kinetics of hormone desensitization and growth hormone stimulation of both tyrosine phosphorylation and serine/threonine phosphorylation. J Biol Chem 271:5929–5940PubMedCrossRefGoogle Scholar
  332. 332.
    Recio MJ, Moreno-Pelayo MA, Kilic SS, Guardo AC, Sanal O, Allende LM, Perez-Flores V, Mencia A, Modamio-Hoybjor S, Seoane E, Regueiro JR (2007) Differential biological role of CD3 chains revealed by human immunodeficiencies. J Immunol 178:2556–2564PubMedGoogle Scholar
  333. 333.
    Reichard P (1978) From deoxynucleotides to DNA synthesis. Fed Proc 37:9–14PubMedGoogle Scholar
  334. 334.
    Reisner Y, Kapoor N, Kirkpatrick D, Pollack MS, Cunningham-Rundles S, Dupont B, al. e (1983) Transplantation for severe combined immunodeficiency with HLA-A, B, D, DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells. Blood 61:341–348PubMedGoogle Scholar
  335. 335.
    Reith W, Mach B (2001) The bare lymphocyte syndrome and the regulation of MHC expression. Annu Rev Immunol 19:331–373PubMedCrossRefGoogle Scholar
  336. 336.
    Renella R, Picard C, Neven B, Ouachee-Chardin M, Casanova JL, Le Deist F, Cavazzana-Calvo M, Blanche S, Fischer A (2006) Human leucocyte antigen-identical haematopoietic stem cell transplantation in major histocompatiblity complex class II immunodeficiency: reduced survival correlates with an increased incidence of acute graft-versus-host disease and pre-existing viral infections. Br J Haematol 134:510–516PubMedCrossRefGoogle Scholar
  337. 337.
    Riballo E, Critchlow SE, Teo SH, Doherty AJ, Priestley A, Broughton B, Kysela B, Beamish H, Plowman N, Arlett CF, Lehmann AR, Jackson SP, Jeggo PA (1999) Identification of a defect in DNA ligase IV in a radiosensitive leukemia patient. Curr Biol 9:699–702PubMedCrossRefGoogle Scholar
  338. 338.
    Riballo E, Doherty AJ, Dai Y, Stiff T, Oettinger MA, Jeggo PA, Kysela B (2001) Cellular and biochemical impact of a mutation in DNA ligase IV conferring clinical radiosensitivity. J Biol Chem 276:31124–31132PubMedCrossRefGoogle Scholar
  339. 339.
    Rich KC, Arnold WJ, Palella T, Fox IH (1979) Cellular immune deficiency with autoimmune hemolytic anemia in purine nucleoside phosphorylase deficiency. Am J Med 67:172–176PubMedCrossRefGoogle Scholar
  340. 340.
    Richetta A, Amoruso GF, Ascoli V, Natale ME, Carboni V, Carlomagno V, Pezza M, Cimillo M, Maiani E, Mattozzi C, Calvieri S (2007) PEL, Kaposi’s sarcoma HHV8+ and idiopathic T-lymphocitopenia CD4+. Clin Ter 158:151–155PubMedGoogle Scholar
  341. 341.
    Rieux-Laucat F, Hivroz C, Lim A, Mateo V, Pellier I, Selz F, Fischer A, Le Deist F (2006) Inherited and somatic CD3zeta mutations in a patient with T cell deficiency. N Engl J Med 354:1913–1921PubMedCrossRefGoogle Scholar
  342. 342.
    Rieux-Laucat F, Le Deist F, Selz F, Fischer A, de Villartay JP (1993) Normal T cell receptor V beta usage in a primary immunodeficiency associated with HLA class II deficiency. Eur J Immunol 23:928–934PubMedCrossRefGoogle Scholar
  343. 343.
    Rijksen G, Kuis W, Wadman SK, Spaapen LJ, Duran M, Voorbrood BS, Staal GE, Stoop JW, Zegers BJ (1987) A new case of purine nucleoside phosphorylase deficiency: enzymologic, clinical, and immunologic characteristics. Pediatr Res 21:137–141PubMedCrossRefGoogle Scholar
  344. 344.
    Roberts JL, Lauritsen JPH, Cooney M, Parrott RE, Sajaroff EO, Win CM, Keller MD, Carpenter JH, Carabana J, Krangel MS, Sarzotti M, Zhong X-P, Wiest DL, Buckley RH (2007) T-B+NK+ severe combined immunodeficiency caused by complete deficiency of the CD3zeta subunit of the T cell antigen receptor complex. Blood 109:3198–3206PubMedCrossRefGoogle Scholar
  345. 345.
    Roger PM, Bernard-Pomier G, Counillon E, Breittmayer JP, Bernard A, Dellamonica P (1999) Overexpression of Fas/CD95 and Fas-induced apoptosis in a patient with idiopathic CD4+ T lymphocytopenia. Clin Infect Dis 28:1012–1016PubMedCrossRefGoogle Scholar
  346. 346.
    Roifman CM (1995) A mutation in zap-70 protein tyrosine kinase results in a selective immunodeficiency. J Clin Immunol 15:52S–62SPubMedCrossRefGoogle Scholar
  347. 347.
    Roifman CM (2000) Human IL-2 receptor alpha chain deficiency. Pediatr Res 48:6–11PubMedCrossRefGoogle Scholar
  348. 348.
    Roifman CM (2004) CD3 delta immunodeficiency. Curr Opin Allergy Clin Immunol 4:479–484PubMedCrossRefGoogle Scholar
  349. 349.
    Roifman CM, Hummel D, Martinez-Valdez H, Thorner P, Doherty PJ, Pan S, Cohen F, Cohen A (1989) Depletion of CD8+ cells in human thymic medulla results in selective immune deficiency. J Exp Med 170:2177–2182PubMedCrossRefGoogle Scholar
  350. 350.
    Roifman CM, Zhang J, Chitayat D, Sharfe N (2000) A partial deficiency of Interleukin-7R alpha is sufficient to abrogate T cell development and cause severe combined immunodeficiency. Blood 96:2803–2807PubMedGoogle Scholar
  351. 351.
    Rooney S, Alt FW, Lombard D, Whitlow S, Eckersdorff M, Fleming J, Fugmann S, Ferguson DO, Schatz DG, Sekiguchi J (2003) Defective DNA repair and increased genomic instability in Artemis-deficient murine cells. J Exp Med 197:553–565PubMedCrossRefGoogle Scholar
  352. 352.
    Rooney S, Sekiguchi J, Whitlow S, Eckersdorff M, Manis JP, Lee C, Ferguson DO, Alt FW (2004) Artemis and p53 cooperate to suppress oncogenic N-myc amplification in progenitor B cells. Proc Natl Acad Sci USA 101:2410–2415PubMedCrossRefGoogle Scholar
  353. 353.
    Rooney S, Sekiguchi J, Zhu C, Cheng HL, Manis J, Whitlow S, DeVido J, Foy D, Chaudhuri J, Lombard D, Alt FW (2002) Leaky Scid phenotype associated with defective V(D) J coding end processing in Artemis-deficient mice. Mol Cell 10:1379–1390PubMedCrossRefGoogle Scholar
  354. 354.
    Roos J, DiGregorio PJ, Yeromin AV, Ohlsen K, Lioudyno M, Zhang S, Safrina O, Kozak JA, Wagner SL, Cahalan MD, Velicelebi G, Stauderman KA (2005) STIM1, an essential and conserved component of store-operated Ca2+ channel function. J Cell Biol 169:435–445PubMedCrossRefGoogle Scholar
  355. 355.
    Rosenfeld RG, Rosenbloom AL, Guevara-Aguirre J (2004) Growth hormone (GH) insensitivity due to primary GH receptor deficiency. Endocr Rev 15:369–390Google Scholar
  356. 356.
    Roth DB, Chang XB, Wilson JH (1989) Comparison of filler DNA at immune, nonimmune, and oncogenic rearrangements suggests multiple mechanisms of formation. Mol Cell Biol 9:3049–3057PubMedGoogle Scholar
  357. 357.
    Roth DB, Menetski JP, Nakajima PB, Bosma MJ, Gellert M (1992) V(D) J recombination: broken DNA molecules with covalently sealed (hairpin) coding ends in scid mouse thymocytes. Cell 70:983–991PubMedCrossRefGoogle Scholar
  358. 358.
    Roth DB, Wilson JH (1986) Nonhomologous recombination in mammalian cells: role for short sequence homologies in the joining reaction. Mol Cell Biol 6:4295–4304PubMedGoogle Scholar
  359. 359.
    Russ G, Esquivel F, Yewdell JW, Cresswell P, Spies T, Bennink JR (1995) Assembly, intracellular localization, and nucleotide binding properties of the human peptide transporters TAP1 and TAP2 expressed by recombinant vaccinia viruses. J Biol Chem 270:21312–21318PubMedCrossRefGoogle Scholar
  360. 360.
    Russel DW, Johnston JA, Noguchi M, Kawamura M, Bacon CM, Friedmann M, Berg M, McVicar DW, Whitthuhn BA, Silvennoinen O, Goldman AS, Schmalsteig FC, Ihle JN, O’Shea JJ, Leonard WJ (1994) Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID. Science 266:1042–1045CrossRefGoogle Scholar
  361. 361.
    Russel DW, Tayebi N, Nakajima H, Riedy MC, Roberts JL, Aman MJ, Migone TS, Noguchi M, Markert ML, Buckley RH, O’Shea JJ, Leonard WJ (1995) Mutation of Jak3 in a patient with SCPI: essential role of Jak3 in lymphoid development. Science 270:797–800CrossRefGoogle Scholar
  362. 362.
    Safford MG, al. e (1997) JAK3: expression and mapping to chromosome 19p12–13.1. Exp Hematol 25:374–386PubMedGoogle Scholar
  363. 363.
    Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155:1151–1164PubMedGoogle Scholar
  364. 364.
    Sakiyama T, Iwase M, Horinouchi K, Akatsuka A, Yoshida Y, Kikuchi T, Shimatake H, Kitagawa T (1989) Clinico-biochemical and molecular studies of purine nucleoside phosphorylase deficiency. Adv Exp Med Biol 253A:73–79PubMedGoogle Scholar
  365. 365.
    Saleem MA, Arkwright PD, Davies EG, Cant AJ, Veys PA (2000) Clinical course of patients with major histocompatibility complex class II deficiency. Arch Dis Child 83:356–359PubMedCrossRefGoogle Scholar
  366. 366.
    Salit RB, Hankey KG, Yi R, Rapoport AP, Mann DL (2007) Detection of CD4(+) T cell antibodies in a patient with idiopathic CD4 T lymphocytopenia and cryptococcal meningitis. Br J Haematol 139:133–137PubMedCrossRefGoogle Scholar
  367. 367.
    Sasaki Y, Iseki M, Yamaguchi S, Kurosawa Y, Yamamoto T, Moriwaki Y, Kenri T, Sasaki T, Yamashita R (1998) Direct evidence of autosomal recessive inheritance of Arg24 to termination codon in purine nucleoside phosphorylase gene in a family with a severe combined immunodeficiency patient. Hum Genet 103:81–85PubMedCrossRefGoogle Scholar
  368. 368.
    Sawabe T, Horiuchi T, Nakamura M, Tsukamoto H, Nakahara K, Harashima SI, Tsuchiya T, Nakano S (2001) Defect of lck in a patient with common variable immunodeficiency. Int J Mol Med 7:609–614PubMedGoogle Scholar
  369. 369.
    Schatz DG, Oettinger MA, Schlissel MS (1992) V(D) J recombination: molecular biology and regulation. Annu Rev Immunol 10:359–383PubMedGoogle Scholar
  370. 370.
    Schorle H, Holtschke T, Hunig T, Schimpl A, Horak I (1991) Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352:621–624PubMedCrossRefGoogle Scholar
  371. 371.
    Schumacher RF, Mella P, Badolato R, Fiorini M, Savoldi G, Giliani S, Villa A, Candotti F, Tampalini A, O’Shea JJ, Notarangelo LD (2000) Complete genomic organization of the human JAK3 gene and mutation analysis in severe combined immunodeficiency by single-strand conformation polymorphism. Hum Genet 106:73–79PubMedCrossRefGoogle Scholar
  372. 372.
    Schwarz K, Gauss GH, Ludwig L, Pannicke U, Li Z, Lindner D, Friedrich W, Seger RA, Hansenhagge TE, Desiderio S, Lieber MR, Bartram CR (1996) Rag Mutations In Human B Cell-Negative Scid. Science 274:97–99PubMedCrossRefGoogle Scholar
  373. 373.
    Seyama K, Nonoyama S, Gangsaas I, Hollenbaugh D, Pabst HF, Aruffo A, Ochs HD (1998) Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome [see comments]. Blood 92:2421–2434PubMedGoogle Scholar
  374. 374.
    Sharfe N, Arpaia E, Roifman CM (2000) CD8 lymphocytopenia casued by ZAP-70 deficiciency. Immunol Allergy Clin North Am 20:77–95CrossRefGoogle Scholar
  375. 375.
    Sharfe N, Dadi HK, Shahar M, Roifman CM (1997) Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor. Proc Natl Acad Sci USA 94:3168–3171PubMedCrossRefGoogle Scholar
  376. 376.
    Shearer WT, Rosenblatt HM, Gelman RS, Oyomopito R, Plaeger S, Stiehm ER, Wara DW, Douglas SD, Luzuriaga K, McFarland EJ, Yogev R, Rathore MH, Levy W, Graham BL, Spector SA (2003) Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol 112:973–980PubMedCrossRefGoogle Scholar
  377. 377.
    Shinkai Y, Rathbun G, Lam KP, Oltz EM, Stewart V, Mendelsohn M, Charron J, Datta M, Young F, Stall AM, et al. (1992) RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D) J rearrangement. Cell 68:855–867PubMedCrossRefGoogle Scholar
  378. 378.
    Shockett PE, Schatz DG (1999) DNA hairpin opening mediated by the RAG1 and RAG2 proteins. Mol Cell Biol 19:4159–4166PubMedGoogle Scholar
  379. 379.
    Sidi Y, Gelvan I, Brosh S, Pinkhas J, Sperling O (1989) Guanine nucleotide metabolism in red blood cells: the metabolic basis for GTP depletion in HGPRT and PNP deficiency. Adv Exp Med Biol 253A:67–71PubMedGoogle Scholar
  380. 380.
    Silva CM (2004) Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis. Oncogene 23:8017–8023PubMedCrossRefGoogle Scholar
  381. 381.
    Simmonds HA, Fairbanks LD, Morris GS, Morgan G, Watson AR, Timms P, Singh B (1987) Central nervous system dysfunction and erythrocyte guanosine triphosphate depletion in purine nucleoside phosphorylase deficiency. Arch Dis Child 62:385–391PubMedCrossRefGoogle Scholar
  382. 382.
    Sinicco A, Maiello A, Raiteri R, Sciandra M, Dassio G, Zamprogna C, Mecozzi B (1996) Pneumocystis carinii in a patient with pulmonary sarcoidosis and idiopathic CD4+ T lymphocytopenia. Thorax 51:446–447: discussion 448–449PubMedCrossRefGoogle Scholar
  383. 383.
    Skoda-Smith S, Douglas VK, Mehta P, Graham-Pole J, Wingard JR (2001) Treatment of post-transplant lymphoproliferative disease with induction chemotherapy followed by haploidentical peripheral blood stem cell transplantation and Rituximab. Bone Marrow Transplant 27:329–332PubMedCrossRefGoogle Scholar
  384. 384.
    Smith DK, Neal JJ, Holmberg SD (1993) Unexplained opportunistic infections and CD4+ T-lymphocytopenia without HIV infection. An investigation of cases in the United States. The Centers for Disease Control Idiopathic CD4+ T-lymphocytopenia Task Force [see comments]. N Engl J Med 328:373–379PubMedCrossRefGoogle Scholar
  385. 385.
    Snyder FF, Jenuth JP, Dilay JE, Fung E, Lightfoot T, Mably ER (1994) Secondary loss of deoxyguanosine kinase activity in purine nucleoside phosphorylase deficient mice. Biochim Biophys Acta 1227:33–40PubMedGoogle Scholar
  386. 386.
    Sobacchi C, Marrella V, Rucci F, Vezzoni P, Villa A (2006) RAG-dependent primary immunodeficiencies. Hum Mutat 27:1174–1184PubMedCrossRefGoogle Scholar
  387. 387.
    Soudais C, de Villartay JP, Le Deist F, Fischer A, Lisowska-Grospierre B (1993) Independent mutations of the human CD3-epsilon gene resulting in a T cell receptor/CD3 complex immunodeficiency. Nat Genet 3:77–81PubMedCrossRefGoogle Scholar
  388. 388.
    Soutar RL, Day RE (1991) Dysequilibrium/ataxic diplegia with immunodeficiency. Arch Dis Child 66:982–983PubMedCrossRefGoogle Scholar
  389. 389.
    Spira TJ, Jones BM, Nicholson JK, Lal RB, Rowe T, Mawle AC, Lauter CB, Shulman JA, Monson RA (1993) Idiopathic CD4+ T-lymphocytopenia–an analysis of five patients with unexplained opportunistic infections [see comments]. N Engl J Med 328:386–392PubMedCrossRefGoogle Scholar
  390. 390.
    Staal GE, Stoop JW, Zegers BJ, Siegenbeek van Heukelom LH, van der Vlist MJ, Wadman SK, Martin DW (1980) Erythrocyte metabolism in purine nucleoside phosphorylase deficiency after enzyme replacement therapy by infusion of erythrocytes. J Clin Invest 65:103–108PubMedCrossRefGoogle Scholar
  391. 391.
    Steimle V, Durand B, Barras E, Zufferey M, Hadam MR, Mach B, Reith W (1995) A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev 9:1021–1032PubMedCrossRefGoogle Scholar
  392. 392.
    Steimle V, Otten LA, Zufferey M, Mach B (1993) Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75:135–146PubMedGoogle Scholar
  393. 393.
    Stephan JL, Vlekova V, Le Deist F, Blanche S, Donadieu J, De Saint-Basile G, Durandy A, Griscelli C, Fischer A (1993) Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients. J Pediatr 123:564–572PubMedCrossRefGoogle Scholar
  394. 394.
    Stephan V, Wahn V, Le Deist F, Dirksen U, Broker B, Muller-Fleckenstein I, Horneff G, Schroten H, Fischer A, de Saint Basile G (1996) Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells. N Engl J Med 335:1563–1570PubMedCrossRefGoogle Scholar
  395. 395.
    Stoop JW, Zegers BJ, Spaapen LJ, Kuis W, Roord JJ, Rijkers GT, Staal GE, Rijksen G, Duran M, Wadman SK (1984) The effect of deoxycytidine and tetrahydrouridine in purine nucleoside phosphorylase deficiency. Adv Exp Med Biol 165 Pt A:61–66PubMedGoogle Scholar
  396. 396.
    Su DM, Navarre S, Oh WJ, Condie BG, Manley NR (2003) A domain of Foxn1 required for crosstalk-dependent thymic epithelial cell differentiation. Nat Immunol 4:1128–1135PubMedCrossRefGoogle Scholar
  397. 397.
    Sultan AS, Xie J, LeBaron MJ, Ealley EL, Nevalainen MT, Rui H (2005) Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells. Oncogene 24:746–760PubMedCrossRefGoogle Scholar
  398. 398.
    Suzuki H, Takahashi Y, Miyajima H (2006) Progressive multifocal leukoencephalopathy complicating X-linked hyper-IgM syndrome in an adult. Intern Med 45:1187–1188PubMedCrossRefGoogle Scholar
  399. 399.
    Tabarki B, Yacoub M, Tlili K, Trabelsi A, Dogui M, Essoussi AS (2003) Familial spastic paraplegia as the presenting manifestation in patients with purine nucleoside phosphorylase deficiency. J Child Neurol 18:140–141PubMedCrossRefGoogle Scholar
  400. 400.
    Tabori U, Mark Z, Amariglio N, Etzioni A, Golan H, Biloray B, Toren A, Rechavi G, Dalal I (2004) Detection of RAG mutations and prenatal diagnosis in families presenting with either T-B- severe combined immunodeficiency or Omenn’s syndrome. Clin Genet 65:322–326PubMedCrossRefGoogle Scholar
  401. 401.
    Takada H, Nomura A, Roifman CM, Hara T (2005) Severe combined immunodeficiency caused by a splicing abnormality of the CD3delta gene. Eur J Pediatr 164:311–314PubMedCrossRefGoogle Scholar
  402. 402.
    Takeshita T, Asao H, Ohtani K, Ishii J, Kumaki S, Tanaka N, Munakata H, Nakumara M, Sugamura K (1992) Cloning of the gamma chain of the human IL-2 receptor. Science 257:379–382PubMedCrossRefGoogle Scholar
  403. 403.
    Tam DA, Jr., Leshner RT (1995) Stroke in purine nucleoside phosphorylase deficiency. Pediatr Neurol 12:146–148PubMedCrossRefGoogle Scholar
  404. 404.
    Tchilian E, Wallace D, Wells R, Flower D, Morgan G, Beverley P (2001) A deletion in the gene encoding the CD45 antigen in a patient with SCID. J Immunol 166:1308–1313PubMedGoogle Scholar
  405. 405.
    Teglund S, McKay C, Schuetz E, van Deursen JM, Stravopodis D, Wang D, Brown M, Bodner S, Grosveld G, Ihle JN (1998) Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 93:841–850PubMedCrossRefGoogle Scholar
  406. 406.
    Thoenes G, Le Deist F, Fischer A, Griscelli C, Lisowska-Grospierre B (1990) Immunodeficiency associated with defective expression of the T cell receptor/CD3 complex. N Engl J Med 322:1399PubMedGoogle Scholar
  407. 407.
    Thomas C, de Saint Basile G, Le Deist F, Theophile D, Benkerrou M, Haddad E, Blanche S, Fischer A (1995) Brief report: correction of X-linked hyper-IgM syndrome by allogeneic bone marrow transplantation. N Engl J Med 333:426–429PubMedCrossRefGoogle Scholar
  408. 408.
    Thompson CB (1995) New insights into V(D) J recombination and its role in the evolution of the immune system. Immunity 3:531–539PubMedCrossRefGoogle Scholar
  409. 409.
    Toita N, Hatano N, Ono S, Yamada M, Kobayashi R, Kobayashi I, Kawamura N, Okano M, Satoh A, Nakagawa A, Ohshima K, Shindoh M, Takami T, Kobayashi K, Ariga T (2007) Epstein-Barr virus-associated B cell lymphoma in a patient with DNA ligase IV (LIG4) syndrome. Am J Med Genet A 143:742–745PubMedGoogle Scholar
  410. 410.
    Tonegawa S (1983) Somatic generation of antibody diversity. Nature 302:575–581PubMedCrossRefGoogle Scholar
  411. 411.
    Toro A, Grunebaum E (2006) TAT-mediated intracellular delivery of purine nucleoside phosphorylase corrects its deficiency in mice. J Clin Invest 116:2717–2726PubMedCrossRefGoogle Scholar
  412. 412.
    Toyabe S, Watanabe A, Harada W, Karasawa T, Uchiyama M (2001) Specific immunoglobulin E responses in ZAP-70-deficient patients are mediated by Syk-dependent T cell receptor signalling. Immunology 103:164–171PubMedCrossRefGoogle Scholar
  413. 413.
    Tsuda M, Horinouchi K, Sakiyama T, Owada M (2002) Novel missense mutation in the purine nucleoside phosphorylase gene in a Japanese patient with purine nucleoside phosphorylase deficiency. Pediatr Int 44:333–334PubMedCrossRefGoogle Scholar
  414. 414.
    Udy GB, Towers RP, Snell RG, Wilkins RJ, Park SH, Ram PA, Waxman DJ, Davey HW (1997) Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci USA 94:7239–7244PubMedCrossRefGoogle Scholar
  415. 415.
    van der Burg M, van Veelen LR, Verkaik NS, Wiegant WW, Hartwig NG, Barendregt BH, Brugmans L, Raams A, Jaspers NGJ, Zdzienicka MZ, van Dongen JJM, van Gent DC (2006) A new type of radiosensitive T-B-Nk+ severe combined immunodeficiency caused by a LIG4 mutation. J Clin Invest 116:137–145PubMedCrossRefGoogle Scholar
  416. 416.
    van Gent DC, Mizuuchi K, Gellert M (1996) Similarities between initiation of V(D) J recombination and retroviral integration. Science 271:1592–1594PubMedCrossRefGoogle Scholar
  417. 417.
    Van Kaer L, Ashton-Rickardt PG, Ploegh HL, Tonegawa S (1992) TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4–8+ T cells. Cell 71:1205–1214PubMedCrossRefGoogle Scholar
  418. 418.
    Vargas J, Gamboa C, Negrin D, Correa M, Sandoval C, Aguiar A, Prieto M, Rodriguez-Morales AJ, De Waard J, Yakrus M (2005) Disseminated Mycobacterium mucogenicum infection in a patient with idiopathic CD4+ T lymphocytopenia manifesting as fever of unknown origin. Clin Infect Dis 41:759–760PubMedCrossRefGoogle Scholar
  419. 419.
    Vella A, Cooper JD, Lowe CE, Walker N, Nutland S, Widmer B, Jones R, Ring SM, McArdle W, Pembrey ME, Strachan DP, Dunger DB, Twells RC, Clayton DG, Todd JA (2005) Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. Am J Hum Genet 76:773–779PubMedCrossRefGoogle Scholar
  420. 420.
    Venzor J, Hua Q, Bressler RB, Miranda CH, Huston DP (1997) Behcet’s-like syndrome associated with idiopathic CD4+ T- lymphocytopenia, opportunistic infections, and a large population of TCR alpha beta+ CD4- CD8- T cells. Am J Med Sci 313:236–238PubMedCrossRefGoogle Scholar
  421. 421.
    Vidarsdottir S, Walenkamp MJ, Pereira AM, Karperien M, van Doorn J, van Duyvenvoorde HA, White S, Breuning MH, Roelfsema F, Kruithof MF, van Dissel J, Janssen R, Wit JM, Romijn JA (2006) Clinical and biochemical characteristics of a male patient with a novel homozygous STAT5b mutation. J Clin Endocrinol Metab 91:3482–3485PubMedCrossRefGoogle Scholar
  422. 422.
    Vig M, Peinelt C, Beck A, Koomoa DL, Rabah D, Koblan-Huberson M, Kraft S, Turner H, Fleig A, Penner R, Kinet JP (2006) CRACM1 is a plasma membrane protein essential for store-operated Ca2+ entry. Science 312:1220–1223PubMedCrossRefGoogle Scholar
  423. 423.
    Villa A, Bozzi F, Sobacchi C, Strina D, Fasth A, Pasic S, Notarangelo LD, Vezzoni P (2000) Prenatal diagnosis of RAG-deficient Omenn syndrome. Prenat Diagn 20:56–59PubMedCrossRefGoogle Scholar
  424. 424.
    Villa A, Santagata S, Bozzi F, Giliani S, Frattini A, Imberti L, Gatta LB, Ochs HD, Schwarz K, Notarangelo LD, Vezzoni P, Spanopoulou E (1998) Partial V(D) J recombination activity leads to Omenn syndrome. Cell 93:885–896PubMedCrossRefGoogle Scholar
  425. 425.
    Villa A, Sobacchi C, Notarangelo LD, Bozzi F, Abinun M, Abrahamsen TG, Arkwright PD, Baniyash M, Brooks EG, Conley ME, Cortes P, Duse M, Fasth A, Filipovich AM, Infante AJ, Jones A, Mazzolari E, Muller SM, Pasic S, Rechavi G, Sacco MG, Santagata S, Schroeder ML, Seger R, Strina D, Ugazio A, Valiaho J, Vihinen M, Vogler LB, Ochs H, Vezzoni P, Friedrich W, Schwarz K (2001) V(D) J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations. Blood 97:81–88PubMedCrossRefGoogle Scholar
  426. 426.
    Villa A, Sobacchi C, Vezzoni P (2001) Recombination activating gene and its defects. Curr Opin Allergy Clin Immunol 1:491–495PubMedCrossRefGoogle Scholar
  427. 427.
    Villard J, Masternak K, Lisowska-Grospierre B, Fischer A, Reith W (2001) MHC class II deficiency: a disease of gene regulation. Medicine (Baltimore) 80:405–418CrossRefGoogle Scholar
  428. 428.
    Vitale M, Zimmer J, Castriconi R, Hanau D, Donato L, Bottino C, Moretta L, de la Salle H, Moretta A (2002) Analysis of natural killer cells in TAP2-deficient patients: expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cells. Blood 99:1723–1729PubMedCrossRefGoogle Scholar
  429. 429.
    von Boehmer H (1992) Thymic selection: a matter of life and death. Immunol Today 13:454–458CrossRefGoogle Scholar
  430. 430.
    Wada T, Takei K, Kudo M, Shimura S, Kasahara Y, Koizumi S, Kawa-Ha K, Ishida Y, Imashuku S, Seki H, Yachie A (2000) Characterization of immune function and analysis of RAG gene mutations in Omenn syndrome and related disorders. Clin Exp Immunol 119:148–155PubMedCrossRefGoogle Scholar
  431. 431.
    Walenkamp MJ, Vidarsdottir S, Pereira AM, Karperien M, van Doorn J, van Duyvenvoorde HA, Breuning MH, Roelfsema F, Kruithof MF, van Dissel J, Janssen R, Wit JM, Romijn JA (2007) Growth hormone secretion and immunological function of a male patient with a homozygous STAT5b mutation. Eur J Endocrinol 156:155–165PubMedCrossRefGoogle Scholar
  432. 432.
    Walker UA, Warnatz K (2006) Idiopathic CD4 lymphocytopenia. Curr Opin Rheumatol 18:389–395PubMedCrossRefGoogle Scholar
  433. 433.
    Wang L, Karlsson A, Arner ES, Eriksson S (1993) Substrate specificity of mitochondrial 2′-deoxyguanosine kinase. Efficient phosphorylation of 2-chlorodeoxyadenosine. J Biol Chem 268:22847–22852PubMedGoogle Scholar
  434. 434.
    Warnatz K, Draeger R, Schlesier M, Peter HH (2000) Successful IL-2 therapy for relapsing herpes zoster infection in a patient with idiopathic CD4+ T lymphocytopenia. Immunobiology 202:204–211PubMedGoogle Scholar
  435. 435.
    Watkins LF, Lewis RA (1987) The metabolism of deoxyguanosine in mitochondria: a characterization of the phosphorylation process which occurs in intact mitochondria. Biochim Biophys Acta 923:103–108PubMedGoogle Scholar
  436. 436.
    Watkins LF, Lewis RA (1987) The metabolism of deoxyguanosine in mitochondria: relationship of the uptake of deoxyguanosine to the electron transport chain and adenosine triphosphate. Arch Biochem Biophys 253:315–321PubMedCrossRefGoogle Scholar
  437. 437.
    Watson AR, Simmonds HA, Webster DR, Layward L, Evans DI (1984) Purine nucleoside phosphorylase (PNP) deficiency: a therapeutic challenge. Adv Exp Med Biol 165 Pt A:53–59PubMedGoogle Scholar
  438. 438.
    Weaver AM, Silva CM (2006) Modulation of signal transducer and activator of transcription 5b activity in breast cancer cells by mutation of tyrosines within the transactivation domain. Mol Endocrinol 20:2392–2405PubMedCrossRefGoogle Scholar
  439. 439.
    Wei YF, Robins P, Carter K, Caldecott K, Pappin DJ, Yu GL, Wang RP, Shell BK, Nash RA, Schar P, et al. (1995) Molecular cloning and expression of human cDNAs encoding a novel DNA ligase IV and DNA ligase III, an enzyme active in DNA repair and recombination. Mol Cell Biol 15:3206–3216PubMedGoogle Scholar
  440. 440.
    Weinberg K, Parkman R (1990) Severe combined immunodeficiency due to a specific defect in the production of interleukin-2. N Engl J Med 322:1718–1723PubMedCrossRefGoogle Scholar
  441. 441.
    Weiss A, Littman DR (1994) Signal transduction by lymphocyte antigen receptors. Cell 76:263–274PubMedCrossRefGoogle Scholar
  442. 442.
    Weller S, Faili A, Garcia C, Braun MC, Le Deist FF, de Saint Basile GG, Hermine O, Fischer A, Reynaud CA, Weill JC (2001) CD40–CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans. Proc Natl Acad Sci USA 98:1166–1170PubMedCrossRefGoogle Scholar
  443. 443.
    Welte T, Leitenberg D, Dittel BN, al-Ramadi BK, Xie B, Chin YE, Janeway CA, Jr., Bothwell AL, Bottomly K, Fu XY (1999) STAT5 interaction with the T cell receptor complex and stimulation of T cell proliferation. Science 283:222–225PubMedCrossRefGoogle Scholar
  444. 444.
    Wengler GS, Lanfranchi A, Frusca T, Verardi R, Neva A, Brugnoni D, Giliani S, Fiorini M, Mella P, Guandalini F, Mazzolari E, Pecorelli S, Notarangelo LD, Porta F, Ugazio AG (1996) In-utero transplantation of parental CD34 haematopoietic progenitor cells in a patient with X-linked severe combined immunodeficiency (SCIDXI). Lancet 348:1484–1487PubMedCrossRefGoogle Scholar
  445. 445.
    Wilhelm M, Weissinger F, Kunzmann V, Muller JG, Fahey JL (2001) Idiopathic CD4+ T cell lymphocytopenia evolving to monoclonal immunoglobulins and progressive renal damage responsive to IL-2 therapy. Clin Immunol 99:298–304PubMedCrossRefGoogle Scholar
  446. 446.
    Willemsen M, De Coninck A, Goossens A, DeCree J, Roseeuw D (1995) Unusual clinical manifestation of a disfiguring necrobiotic granulomatous disease. J Am Acad Dermatol 33:887–890PubMedCrossRefGoogle Scholar
  447. 447.
    Willerford DM, Swat W, Alt FW (1996) Developmental regulation of V(D) J recombination and lymphocyte differentiation. Curr Opin Genet Dev 6:603–609PubMedCrossRefGoogle Scholar
  448. 448.
    Williams SR, Goddard JM, Martin DW, Jr. (1984) Human purine nucleoside phosphorylase cDNA sequence and genomic clone characterization. Nucleic Acids Res 12:5779–5787PubMedCrossRefGoogle Scholar
  449. 449.
    Winkelstein JA, Marino MC, Ochs H, Fuleihan R, Scholl PR, Geha R, Stiehm ER, Conley ME (2003) The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine (Baltimore) 82:373–384CrossRefGoogle Scholar
  450. 450.
    Wiszniewski W, Fondaneche MC, Lambert N, Masternak K, Picard C, Notarangelo L, Schwartz K, Bal J, Reith W, Alcaide C, de Saint Basile G, Fischer A, Lisowska-Grospierre B (2000) Founder effect for a 26-bp deletion in the RFXANK gene in North African major histocompatibility complex class II-deficient patients belonging to complementation group B. Immunogenetics 51:261–267PubMedCrossRefGoogle Scholar
  451. 451.
    Wiszniewski W, Fondaneche MC, Le Deist F, Kanariou M, Selz F, Brousse N, Steimle V, Barbieri G, Alcaide-Loridan C, Charron D, Fischer A, Lisowska-Grospierre B (2001) Mutation in the class II trans-activator leading to a mild immunodeficiency. J Immunol 167:1787–1794PubMedGoogle Scholar
  452. 452.
    Woo Y, Wright SM, Maas SA, Alley TL, Caddle LB, Kamdar S, Affourtit J, Foreman O, Akeson EC, Shaffer D, Bronson RT, Morse HC, 3rd, Roopenian D, Mills KD (2007) The nonhomologous end joining factor Artemis suppresses multi-tissue tumor formation and prevents loss of heterozygosity. Oncogene 26:6010–6020PubMedCrossRefGoogle Scholar
  453. 453.
    Wright CA, Kozik P, Zacharias M, Springer S (2004) Tapasin and other chaperones: models of the MHC class I loading complex. Biol Chem 385:763–778PubMedCrossRefGoogle Scholar
  454. 454.
    Xi S, Zhang Q, Dyer KF, Lerner EC, Smithgall TE, Gooding WE, Kamens J, Grandis JR (2003) Src kinases mediate STAT growth pathways in squamous cell carcinoma of the head and neck. J Biol Chem 278:31574–31583PubMedCrossRefGoogle Scholar
  455. 455.
    Yabe T, Kawamura S, Sato M, Kashiwase K, Tanaka H, Ishikawa Y, Asao Y, Oyama J, Tsuruta K, Tokunaga K, Tadokoro K, Juji T (2002) A subject with a novel type I bare lymphocyte syndrome has tapasin deficiency due to deletion of 4 exons by Alu-mediated recombination. Blood 100:1496–1498PubMedCrossRefGoogle Scholar
  456. 456.
    Yarnell Schultz H, Landree MA, Qiu JX, Kale SB, Roth DB (2001) Joining-deficient RAG1 mutants block V(D) J recombination in vivo and hairpin opening in vitro. Mol Cell 7:65–75PubMedCrossRefGoogle Scholar
  457. 457.
    Yates F, Malassis-Seris M, Stockholm D, Bouneaud C, Larousserie F, Noguiez-Hellin P, Danos O, Kohn DB, Fischer A, de Villartay JP, Cavazzana-Calvo M (2002) Gene therapy of RAG-2-/- mice: sustained correction of the immunodeficiency. Blood 100:3942–3949PubMedCrossRefGoogle Scholar
  458. 458.
    Zanelli G, Sansoni A, Ricciardi B, Ciacci C, Cellesi C (2001) Muscular-skeletal cryptococcosis in a patient with idiopathic CD4+ lymphopenia. Mycopathologia 149:137–139PubMedCrossRefGoogle Scholar
  459. 459.
    Zhang SL, Yeromin AV, Zhang XH, Yu Y, Safrina O, Penna A, Roos J, Stauderman KA, Cahalan MD (2006) Genome-wide RNAi screen of Ca(2+) influx identifies genes that regulate Ca(2+) release-activated Ca(2+) channel activity. Proc Natl Acad Sci USA 103:9357–9362PubMedCrossRefGoogle Scholar
  460. 460.
    Zhu C, Johansson M, Permert J, Karlsson A (1998) Phosphorylation of anticancer nucleoside analogs by human mitochondrial deoxyguanosine kinase. Biochem Pharmacol 56:1035–1040PubMedCrossRefGoogle Scholar
  461. 461.
    Zhu C, Roth DB (1995) Characterization of coding ends in thymocytes of scid mice: implications for the mechanism of V(D) J recombination. Immunity 2: 101–112PubMedCrossRefGoogle Scholar
  462. 462.
    Ziegner UH, Ochs HD, Schanen C, Feig SA, Seyama K, Futatani T, Gross T, Wakim M, Roberts RL, Rawlings DJ, Dovat S, Fraser JK, Stiehm ER (2001) Unrelated umbilical cord stem cell transplantation for X-linked immunodeficiencies. J Pediatr 138:570–573PubMedCrossRefGoogle Scholar
  463. 463.
    Zimmer J, Andres E, Donato L, Hanau D, Hentges F, de la Salle H (2005) Clinical and immunological aspects of HLA class I deficiency. Q J Med 98:719–727Google Scholar
  464. 464.
    Zimmer J, Bausinger H, Andres E, Donato L, Hanau D, Hentges F, Moretta A, de la Salle H (2007) Phenotypic studies of natural killer cell subsets in human transporter associated with antigen processing deficiency. PLoS ONE 2:e1033PubMedCrossRefGoogle Scholar
  465. 465.
    Zimmer J, Donato L, Hanau D, Cazenave JP, Moretta A, Tongio MM, de la Salle H (1999) Inefficient protection of human TAP-deficient fibroblasts from autologous NK cell-mediated lysis by cytokines inducing HLA class I expression. Eur J Immunol 29:1286–1291PubMedCrossRefGoogle Scholar
  466. 466.
    Zimmer J, Donato L, Hanau D, Cazenave JP, Tongio MM, Moretta A, de la Salle H (1998) Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome). J Exp Med 187:117–122PubMedCrossRefGoogle Scholar
  467. 467.
    Zonios DI, Falloon J, Huang CY, Chaitt D, Bennett JE (2007) Cryptococcosis and idiopathic CD4 lymphocytopenia. Medicine (Baltimore) 86:78–92CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2008

Authors and Affiliations

  • Françoise Le Deist
    • 1
  • Despina Moshous
    • 2
  • Steven J. Howe
    • 3
  • Amit Nahum
    • 4
  • Fotini D. Kavadas
    • 4
  • Elana Lavine
    • 4
  • Chaim M. Roifman
    • 4
  • Alain Fischer
    • 5
  1. 1.Department de Microbiologie et d’Immunologie Hospital Saint JustineUniversity of MontréalMontrealCanada
  2. 2.Unité d’Immunologie et Hématologie PédiatriqueAP-HP Hôpital Necker-Enfants MaladesParis Cedex 15France
  3. 3.Molecular Immunology Unit Institute of Child HealthUniversity College LondonLondonUK
  4. 4.Division of Immunology and Allergy Department of Paediatrics The Hospital for Sick ChildrenThe University of TorontoTorontoCanada
  5. 5.Unité d’Immunologie et Hématologie PédiatriqueHôpital Necker-Enfants MaladesParisFrance

Personalised recommendations